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ABSTRACT 
 Forkhead box (Fox) family transcription factors are highly conserved and play 
essential roles in a wide range of cellular and developmental processes. This family was 
named after the ectopic head structures observed in mutants of the Drosophila gene 
forkhead (fkh). Since the discovery of fkh, hundreds of Fox genes have been identified in 
organisms ranging from yeasts to humans, making it one of the largest but least explored 
families of higher eukaryotic transcription factors. The NIH Undiagnosed Diseases 
Program (NIH UDP), a clinical site of the NIH Undiagnosed Diseases Network (UDN), 
identified a variant (p.M280L) in a single allele of the FOXR1 gene in an individual with 
severe neurological symptoms including postnatal microcephaly, progressive brain 
atrophy, and global developmental delay. The de novo missense variant in FOXR1 converts 
a highly conserved methionine residue at amino acid 280 to leucine and was predicted to 
contribute to the individual’s disease. The goal of this research is to investigate the 
biological role of FOXR1 and to determine how the M280L mutant leads to disease 
pathogenesis.   
At the protein level, the M280L mutant impaired FOXR1 expression and induced 
a nuclear aggregate phenotype when overexpressed in HEK 293T and COS7 cells due to 
 
 viii 
protein misfolding and proteolysis. A FOXR1 C-terminal truncation mutant mimicked the 
M280L phenotype, suggesting that the C-terminal sequences of FOXR1 are important for 
FOXR1 protein stability. RNAseq and pathway analysis in HEK 293T cells indicated that 
FOXR1 acts as both transcriptional activator and repressor, playing central roles in heat 
shock response, chaperone cofactor-dependent protein refolding, and cellular response to 
stress. Indeed, FOXR1 expression is increased in HEK 293T in response to cellular stress, 
a process in which FOXRI directly controls HSPA6, HSPA1A and DHRS2 transcription. In 
contrast, the ability of the M280L mutant to respond to stress is compromised, in part due 
to impaired regulation of downstream target genes that are involved in the stress response 
pathway. Combined, these results suggest that FOXR1 plays a role in cellular stress and 
that impairment of these functions may contribute to the disease phenotypes seen in the 
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CHAPTER ONE  
Introduction 
1.1 Transcription factors overview   
The regulation of gene expression is vital in all living organisms. This process starts 
with transcription, whereby the information in a DNA strand is transcribed into a new 
molecule of RNA. The transfer of genetic information will be used by the cell for protein 
production. In bacteria, all genes are transcribed by a single RNA polymerase, whereas 
three distinct nuclear RNA polymerases are necessary for eukaryotic cells. RNA 
polymerase II transcribes protein-coding genes to yield mRNAs, while ribosomal RNAs 
(rRNAs) and transfer RNAs (tRNAs) are transcribed by RNA polymerases I and III 
(reviewed inSperling, 2007). In the synthesis of mRNA, RNA polymerase II is only able 
to initiate transcription when distinct cofactors are present (figure 1.1). Transcription of 
protein-coding genes occurs in three steps: initiation, elongation, and termination. 
Initiation begins when RNA polymerase II binds to the DNA upstream of the gene at the 
specialized sequence called a promoter. Once it is positioned there, the separation of the 
two DNA strands is initiated. Elongation follows with the addition of nucleotides to the 
precursor mRNA (pre-mRNA) by the RNA polymerase as it moves along the template 
DNA strand. Termination signals the end of transcription, and for RNA polymerase II 
transcripts, this process is more complex. In summary, a poly-A tail is added to the pre-
mRNA and at the same time, the strand is cleaved by a protein complex, displacing the 




continually, instead, transcription is controlled individually for each gene by proteins 
called transcription factors (TFs). 
TFs are proteins central to the control system that regulates gene expression. They 
orchestrate important cellular processes, including cell division, growth, migration, and 
the spatial-temporal organization during embryonic development. Basic concepts of gene 
transcription were established in bacterial systems (Jacob & Monod, 1961), and 
subsequent functional studies in eukaryotes have prompted the present model for gene 
regulation (Lelli et al, 2012). Even though the mechanisms of transcription are 
fundamentally similar in all cells, it is more complex in eukaryotic cells than in bacteria. 
Eukaryotic transcription is influenced by various conditions, including TFs affinity for 
particular DNA sequences, the ability of TFs to interact with other proteins, the presence 
of different cell stimuli, and underlying chromatin structure, which varies amongst cells 
and tissues. This facilitates the intricate control of gene expression necessary to regulate 
transcription in multicellular organisms. Progress has been made to create a unified 
picture of transcription control; however, there is still more to be learned about how 
molecular properties of TFs give rise to complex behavior of transcription networks.  
Typically, TFs work by binding to DNA regulatory sequences of their target 
genes in order to alter the rate of gene transcription. TFs can be divided into two 
functional groups: (1) general TFs that bind promoter regions associated with RNA 
polymerase II, and (2) sequence-specific TFs that bind to several regulatory sites 
(Mitchell & Tjian, 1989). Sequence-specific TFs can either act as transcription activators 




DNA or the auxiliary components and altering the state of the chromatin at the gene 
regulatory regions, respectively. A single TF can bind numerous regulatory sites around 
the genome, thus controlling the expression of different genes.  This may require the 
formation of dimers, which can form between two identical molecules (homodimers) or 
between different molecules (heterodimers). In rare cases, a TF may require the presence 
of a partner to induce a conformation change in order to bind specifically to DNA.  
In eukaryotic cells, TFs are generally modular in nature. In other words, they have 
the ability to interact with the genome via DNA-binding domains and to simultaneously 
bind to other regulatory proteins via separate activation domains (Frankel & Kim, 1991). 
This allows for the possibility to generate novel mechanisms of transcription regulation. 
This modular feature was first recognized through studies of yeast activators such as 
Gcn4 (Hope & Struhl, 1986) and Gal4 (Ma & Ptashne, 1987), and mammalian activators 
such as glucocorticoid receptors (Miesfeld et al, 1987) and Sp1 (Courey & Tjian, 1988). 
These studies showed that TFs contained separable DNA-binding and activation domains 
in various domain-swapping experiments that generated functional chimeric TFs. 
Currently, this feature is utilized by synthetic biologists to recapitulate and study how 
transcriptional regulatory complexes assemble and how TFs wire together in transcription 
networks.  Khalil and colleagues have utilized artificial Zinc Finger (ZF) proteins as core 
building blocks to construct and understand complex transcription functions and 
circuitry. They showed that subtle perturbations to these modular proteins can transform 





DNA-binding domains of TFs are well-conserved and adopt different structures.  
Interaction of this domain with DNA can be established through alpha helices, beta 
sheets, or disordered regions.  DNA-binding sites are named according to their structural 
characteristics (motifs), and most organisms contain several TFs that share the same type 
of DNA-binding domain. Consequently, TFs are sometimes classified in families that 
receive the name of the respective DNA-binding domain. Amongst the most common 
motifs are ZFs (glucocorticoid receptors), the helix-turn-helix (Forkhead TFs), and the 
leucine zipper (Activating Transcription Factor-2) (reviewed in Lambert et al, 2018). 
These three-dimensional structural motifs allow for the proteins to interact with the 
double-helix of DNA.  However, binding of a TF to DNA per se does not activate 
transcription. Transcription only occurs when supporting protein complexes are recruited. 
The activation domain of TFs provide this function by specifying sites for protein-protein 
interactions with auxiliary proteins termed GTFs including TFIIB, TFIID, TFIIF, TFIIE, 
and TFIIH. Some of these interactors include coactivators, histone acetyltransferases, 
histone deacetylases, kinases, chromatin remodelers, and methylases, which are essential 
to gene regulation.  
TFs can be activated in the nucleus, while bound to DNA, or in the cytoplasm. 
One mechanism of transcription factor activation in the cytoplasm results in the exposure 
of the nuclear localization signal (NLS) that targets the TFs to the nucleus (Boulikas, 
1994). Ongoing studies have shown that post-translational modifications (PTMs) of TFs 
is a dynamic mechanism that impacts DNA binding, protein-protein interactions, 




studied includes phosphorylation, acetylation, sumoylation, ubiquitination, and 
glycosylation, and methylation (Filtz et al, 2014). For example, phosphorylation and 
acetylation of p65 NF-κB have been shown to alter the association of supporting protein 
complexes, and to change its gene expression profile (Huang et al, 2010). Sumoylation of 
TFs, such as Activator Protein-2 (AP2) and Sp3, is associated with the repression of their 
transcription activation (Eloranta & Hurst, 2002; Ross et al, 2002). Similarly, 
glycosylation of the cyclic AMP response element-binding factor (CREB), an essential 
regulator in synaptic plasticity in neurons, disrupts important sites for protein interaction 
and repressing the transcriptional activity of CREB in vitro (Lamarre-Vincent & Hsieh-
Wilson, 2003).  
Recent studies have elucidated intricate mechanisms of gene expression that are 
misregulated in disease including diabetes, obesity, and brain disorders. Many of these 
diseases are caused by mutations in TFs. For instance, MYC is a TF and the most 
frequently amplified oncogene and misregulation of MYC is associated with tumor 
aggression (Lin et al, 2012). Likewise, the misregulation of NF-κB, an immune response 
transcriptional regulator, has been associated with various diseases including, 
inflammatory and autoimmune disorders, improper immune development and cancer (Liu 
et al, 2017).  Furthermore, mutations in the gene expression programs of pancreatic cells 
can result in various forms of adult-onset diabetes (Malecki, 2005; Maestro et al, 2007). 
Altogether, our understanding of TFs and their transcriptional regulatory networks has 
become increasingly relevant, as it gives new insights into the intricate mechanisms 




1.2 Forkhead transcription factors  
The Forkhead Box (FOX) family of TFs are evolutionarily conserved proteins 
ranging from metazoans and fungi to humans (Figure 1.2A). They are key regulators of a 
wide variety of biological processes including, but are not limited to, gastrulation (Ang & 
Rossant, 1994; Weinstein et al, 1994), stem cell function and maintenance (Sackett et al, 
2009; Aoki et al, 2016), and cell cycle control (Hannenhalli & Kaestner, 2009). The 
forkhead (fkh) gene was originally detected in the Drosophila melanogaster based on a 
mutagenesis screen.  The fkh mutant fly embryos have a two spiked-head (forkhead) 
structure that is a result of a defective homeotic transformation of portions of the anterior 
and posterior gut (Weigel et al, 1989). Utilizing cloning techniques, Weigel and 
colleagues identified the gene responsible for the forkhead phenotype, but found no 
sequence similarity to known protein motifs at the time. However, they noted the 
presence of a NLS which suggested a role as a TF. It wasn’t until the discovery of the 
DNA-binding domain of the mammalian hepatocyte nuclear factor 3 (HNF3) in rat, also 
known as Forkhead Box A1 (FOXA1), that the similarity between the two proteins were 
observed. It became clear then that these two proteins classified a novel TF family. The 
rapid accumulation of sequences by various laboratories has contributed to the use of 
numerous names and classification schemes since the identification of first member. 
However, a standardized nomenclature was stablished and these TFs were aptly named 
Forkhead Box (Fox) family of TFs for the characteristic DNA-binding motif (Weigel & 
Jackle, 1990; Lai et al, 2001).  Since the cloning of fkh, numerous FOX genes have been 




sequence similarity outside the forkhead DNA-binding domain. To date, Fox proteins are 
among the largest TF families and are involved in a broad range of biological processes 
with notable functional diversity. The number of known Fox genes varies widely between 
organisms and an increase in number is observed in animals with complex body plans. In 
humans, there are 50 Fox family members classified in 19 subfamilies (FOXA to FOXS). 
There are 44 members in the mouse genome, in which all have human orthologues. 
Drosophila melanogaster has 18, Caenorhabditis elegans has 16, and Xenopus has 45 fox 
genes. Since Xenopus fox family members express during early embryogenesis, their 
models have been integral to elucidating mechanisms of Fox protein expression patterns 
in early embryogenesis (Pohl & Knochel, 2005).   
 The winged-helix DNA-binding domain is evolutionary conserved between all 
members of the Fox family of TFs (Figure 1.2 B-C). For instance, the amino acid 
similarity between Drosophila Melanogaster fkh and the human FOXA1 protein is 90% 
identical. The wing-helix motif was first observed by Clark and colleagues where they 
used X-ray crystallography to determine the three-dimensional structure of Forkhead Box 
A3 (FOXA3) bound to a DNA target. They coined the term winged-helix to describe the 
canonical structure, which comprises three α-helices connected via a small β-sheet to a 
pair of loops resembling butterfly wings or a “winged-helix” (Clark et al, 1993). In 
available structures of fkh domains, a region near the terminal end of helix 3 contains the 
established canonical recognition site (Carlsson & Mahlapuu, 2002).  
Despite the high degree of conservation identity in their DNA-binding domain, 




binding specificity between the different Fox proteins has been linked to subtle amino 
acids changes in the region adjacent to the DNA recognition helix. Analysis of chimeric 
proteins of the rat Fox family members identified a 20 amino acid region in the third 
alpha helix of the fkh DNA-binding domain that is essential for specificity. When the 20 
amino acid region in rat Foxa2 was replaced with corresponding residues from rat Foxq1, 
it enabled Foxa2 to recognize and bind only Foxq1 specific DNA-binding sites (Overdier 
et al, 1994). Notably, this short amino acid sequence was shown by nuclear magnetic 
resonance (NMR) to have different secondary structures between forkhead TFs (Marsden 
et al, 1998). However, with the determination of three-dimensional structures of several 
fkh domains using X-ray crystallography or NMR, it became apparent that secondary 
structure elements could not explain distinct DNA binding specificities. For example, 
Forkhead Box C2 (FOXC2) and Forkhead Box O4 (FOXO4) have close to identical 
three-dimensional folds, but bind to different target sequences (van Dongen et al, 2000; 
Weigelt et al, 2001). Nakagawa and colleagues proposed a new mechanism in which 
binding specificity is determined between Fox proteins. A phylogenetic analysis of the 
DNA-binding specificity showed that some Fox proteins are able to recognize alternate 
DNA-binding motifs and switch between two conformations with distinct DNA-binding 
specificity (Nakagawa et al, 2013). 
The functional diversity between Fox protein families can be attributed to their 
distinct protein sequences outside the fkh DNA-binding domain, through differences in 
interacting partners, such as protein modifiers, and to differences in spatial and temporal 




was generated, Zaret and colleagues observed that it highly resembled that of a linker 
histone, a nucleosome-binding protein. Thus, this feature gives the FOXA subclass access 
to closed chromatin, a pioneer TF function with the unique property of binding directly to 
condensed chromatin (Zaret & Carroll, 2011; Iwafuchi-Doi et al, 2016). 
Members of the Forkhead Box P (FOXP) subfamily are also unique in that they 
can form homo-and heterodimers, made possible by an evolutionary conserved region, 
containing a ZF, and a leucine zipper motif (Li et al, 2004; Mozzi et al, 2016). Structural 
FOXP protein models show that dimerization prevents adjacent binding on the same 
DNA strand, indicating that FOXP TFs can function to bring together distal areas of the 
chromatin (Stroud et al, 2006). Furthermore, Forkhead Box M1 (FOXM1), the sole 
member of the FOXM subclass, is able to autoregulate its activity by folding back the N-
terminal repressor domain to attenuate the transcriptional activity of the transactivation 
domain (Zona et al, 2014).   
The FOXO family of proteins, known for their roles in cell cycle, longevity, and 
metabolism, are tightly regulated through protein interactions and PTMs (Calnan & 
Brunet, 2008; Smith & Shanley, 2010; Putker et al, 2013). FOXOs are transcription 
activators, with their activity inhibited by growth factor signaling and insulin.  
Phosphorylation of FOXO has been shown to modify DNA-binding. In response to 
growth signals, AKT/protein kinase B (PKB) phosphorylates FOXO proteins, leading to 
their nuclear exclusion by the 14-3-3 scaffolding protein (Tzivion & Hay, 2011). In turn, 
phosphorylation of FOXO proteins by the mammalian Sterile 20-like kinase-1 (MST1) 




translocation back to the nucleus (Lehtinen et al, 2006).  Temporal regulation of a Fox 
protein can also be observed on the FOXA orthologue, pha-4, in Caenorhabditis elegans. 
Pha-4 plays a role in formation of the entire pharynx and its expression increases as 
development progresses. Pha-4 expression is low in early development when high affinity 
pha-4 promoters are activated. Later in development, when pha-4 low affinity promoters 
are expressed, the protein expression is increased. This precise spatial-temporal dosage of 
pha-4 is critical because any alterations lead to developmental abnormalities (Gaudet & 
Mango, 2002). 
Fox TFs are key effectors of many signaling pathways including Wnt/β-catenin, 
sonic hedgehog, insulin/IGF, TGF-β, and MAPK. It is no surprise that perturbations, 
however small, to these proteins are typically detrimental. For this reason, mutations, and 
dysregulation of FOX genes are associated with countless diseases. In cancer, Fox 
proteins are the main contributors of the major hallmarks including invasion, metastasis, 
and cell death resistance. The FOXC subfamily, known for its function in cardiovascular 
development, was found to trigger the epithelial-to-mesenchymal transition (EMT) 
phenotype in hepatocellular carcinoma (Xia et al, 2013). This subfamily is also 
overexpressed in many types of cancers, including lung, breast, stomach, and ovarian 
cancers (Kume, 2012; Wang et al, 2018b). Like FOXCs, FOXM1 and FOXQ1 facilitate 
the EMT process (Park et al, 2011; Tang et al, 2018). FOXM1 is considered to be a 
master regulator of tumorigenesis and metastasis (Raychaudhuri & Park, 2011). 
Overexpression of FOXM1 has been observed in most common cancers and is linked to 




breast cancer cells lines in vitro and in vivo drastically diminished proliferation and 
prevented tumorigenesis (Yang et al, 2013). Furthermore, the Forkhead box F1 
(FOXF1), a p53 target gene, has been shown to promote invasion and migration in human 
oral and colorectal cancer cell lines (Tamura et al, 2014).  
In chronic inflammatory disease, FOXP3 is a key regulator of immune response.  
Foxp3 null mice develop a systemic autoimmune syndrome (Brunkow et al, 2001), and 
mutants have organ-specific autoimmune diseases such as Type-1 diabetes and 
inflammatory bowel disease (Bennett et al, 2001; Wildin et al, 2001). Forkhead Box N1 
(FOXN1) is a key regulator of patterning and cell-fate decisions in thymic and epithelial 
cells. A mutation in FOXN1 causes T-cell immunodeficiency due to thymic agenesis, 
called Nude/SCID syndrome, and it leads to a hairless phenotype in mice and humans. 
Forkhead Box H1 (FOXH1) has been implicated in human congenital heart disease. 
Lenhart and colleagues have found that the FOXH1 is essential for cell responsiveness to 
both Nodal and Bmp signaling pathways during the development of cardiac asymmetry 
(Lenhart et al, 2013).  Together, these studies indicate that Fox proteins play pivotal roles 
in the development and maintenance of physiological homeostasis. Their various roles in 
disease progression have made them potential therapeutic targets. 
1.3 Roles of forkhead transcription factors in the brain 
The complex architecture of the brain requires precise control over the timing of 
proliferation, migration, and differentiation of neuronal cells during development. These 
developmental processes are exquisitely controlled and require intricate gene regulation. 




right cell, at the right time, and in the appropriate dosage. There are a variety of 
neurodevelopmental conditions related to transcription factor abnormalities, indicating 
that these proteins are critical for the proper development and function of the brain. 
Human genetic analyses show that several FOX TFs have important biological functions 
in brain development. Mutations in FOX genes have been shown to impact brain 
development and neuronal function. 
Forkhead Box G1 (FOXG1), formerly named Brain Factor-1 (BF-1), is one of the 
earliest TFs expressed in the nervous cell types and tissues. FOXG1 is considered to be a 
pioneer TF due to its unique property of binding and opening condensed chromatic sites 
in early brain development. FOXG1 is expressed primarily in the telencephalon, but its 
expression has been observed in the cerebral cortex, retina, and olfactory epithelial cells 
(Pauley et al, 2006). Attention to FOXG1 function spiked when severe microcephaly was 
observed in a foxg1 homozygous knockout mice (Xuan et al, 1995; Martynoga et al, 
2005). A dramatic reduction in size of the cerebral hemispheres was observed, 
highlighting the failure of the ventral telencephalon to develop. Later studies showed that 
FOXG1 interacts with the global transcriptional corepressors of the Groucho/transducin-
like Enhancer of split (TLE) family (Yao et al, 2000). These findings suggest that in the 
developing telencephalon, FOXG1 acts as a transcriptional repressor, coordinating the 
control of neural progenitor cell proliferation with the timing of differentiation.  
FOXG1 has also been implicated in establishing cortical layers and axon 
trajectory in the corpus callosum. This concept was first noted in a young female 




(Shoichet et al, 2005). The affected individual presented with structural brain 
abnormalities including microcephaly and agenesis of the corpus callosum. After this 
individual was identified, individuals with similar phenotypes also showed a disruption to 
the FOXG1 chromosome locus. To further understand the molecular mechanism 
underlining FOXG1’s role in brain organization, conditional deletions of foxg1 from 
pyramidal neurons using CRE/LoxP system were created (Cargnin et al, 2018). They 
showed that the cerebral cortex was thinner, the ventricles were enlarged, and the 
intermediate zone was undefined in foxg1 conditional knockout mice. The corpus 
callosum was also absent and the hippocampus failed to develop. This deficit was 
attributed to foxg1’s ability to form a complex with the transcriptional repressor protein 
58 (Rp58). This complex then binds and represses a set of genes including Robo1, Slit3, 
and Reelin that regulate neuronal migration and axon guidance.  
FOXG1 is also critical for maintaining the excitatory/inhibitory neuron balance in 
the brain. Mariari and colleagues generated induced-pluripotent stem cells (iPSCs) lines 
from individuals from four different families that included an autism spectrum disorder 
(ASD) proband. The iPSCs were then differentiated into three-dimensional organoids and 
transcriptome and gene network analyses were performed in the ASD-derived organoids 
(Mariani et al, 2015). While an underlying mutation could not be found, gene profile 
analysis showed overexpression of FOXG1 in the brain organoid. Further investigation 
revealed an overproduction of GABAergic inhibitory neurons, but no alteration in 
glutamate neurons, creating an imbalance in glutamate/GABA neuron ratio. Utilizing 




at least in part, to the ubiquitous expression of FOXG1, which promotes the proliferation 
and a number of genes that drive GABAergic neuron fate. In addition, they observed that 
ASD symptom severity correlated positively with an FOXG1 expression.  
The FOXP subclass of TFs are involved in the development and function of 
several tissues, including the central nervous system (CNS). Three of this subfamily's 
four members, FOXP1, FOXP2, and FOXP4, are highly homologous and expressed 
abundantly during early brain development (Lai et al., 2001; Takahashi et al, 2009). They 
play important roles in neurogenesis, neurite outgrowth, and dendrite morphogenesis 
(Vernes et al, 2011). The expression patterns of these three FOXP genes overlap, but 
their spatial expressions are very different. The most notable TF in the FOXP subfamily 
is FOXP2, which was the first associated with speech acquisition and processing. The 
link between FOXP2 and speech was discovered in a study of a family (KE family) with 
a shared inherited speech disorder called verbal dyspraxia (Nudel & Newbury, 2013). 
Following a genome-wide search, FOXP2 was identified as the gene responsible for the 
family’s speech disorder. Researchers found a point mutation in the fkh domain of the 
FOXP2 gene occurring in every affected family member, but lacking in unaffected 
members (Lai et al, 2000). This single amino acid alteration caused a loss of function of 
one copy of the protein and the remaining copy was insufficient for FOXP2 function. 
Additional heterozygous FOXP2 mutations have been identified and all lead to severe 
speech and neuropsychiatric disorders and mild cognitive impairments (Nudel & 
Newbury, 2013). Although language is unique to humans, the FOXP2 ortholog is present 




song learning and production and its expression patterns are strikingly similar to human 
fetal brain. In fact, in situ hybridization analyses for foxp1/2 in songbirds revealed a 
corticostriatal expression pattern corresponding with the structure aberrations in brain 
structures of affected KE family members.  
Since the discovery of the role of FOXP2 in language processing, various studies 
have highlighted the role of the FOXP subfamily in various brain functions. FOXP1 and 
2 have been linked to ASDs. Utilizing chromatin immunoprecipitation coupled to 
microarrays, Spiteri and colleagues uncovered various FOXP2 downstream target genes 
in the brain that overlap with known ASD genes (Spiteri et al, 2007). Detailed studies 
demonstrated that FOXP2 directly regulates the expression of two specific ASD 
candidate genes, Contactin Associated Protein-2 and Met Receptor Tyrosine Kinase 
(Vernes et al, 2008; Mukamel et al, 2011). Another study observed ASD behavioral 
phenotypes, including decreased social interest and increased rate of repetitive behaviors 
in mouse brains deleted for foxp1 (Bacon et al, 2015). Human mutations in FOXP1 have 
been also identified, and associated with learning disabilities, language deficits, and 
delayed motor development (Horn et al, 2010; Sollis et al, 2016; Sollis et al, 2017). 
Other functional studies on FOXP1 revealed that a loss of foxp1 in mice changed motor 
neuron connectivity (Dasen et al, 2008). Foxp1 was shown to help guide the projection of 
motor axons to surrounding targets during spinal cord development. Despite extensive 
evidence showing FOXP4 is expressed ubiquitously in the brain, functional studies have 
not been explored. However, Tam and colleagues showed that FOXP4 is involved in 




slices, the organization of Purkinje cell dendritic arbors was highly impaired as well as 
the radial alignment of Bergmann glial fibers (Tam et al, 2011).  
The FOXO subclass of TFs are key regulators in an array of cellular functions, 
but have emerged as critical players in the CNS. All mammalian FOXO members 
(FOXO1, FOXO3, FOXO4, and FOXO6) are expressed in the brain with different spatial 
patterns and functions (Hoekman et al, 2006). However, of the four homologs only 
FOXO1, 3, and 6 are the most implicated in neuronal function. Their roles include stem 
cell maintenance and neuronal fate and survival. FOXO3 plays a protective role in neural 
stem progenitor cells (NPCs). Loss of foxo3 in NPCs increased reactive oxygen species 
(ROS) levels in mice, suggesting foxo3 plays a vital role in maintaining redox balance in 
these cells (Yeo et al, 2013). Additionally, FOXO3 has been implicated in NPC cell fate 
by inhibiting Achaete-Scute Family BHLH Transcription Factor 1 (ACL1) dependent 
neurogenesis (Webb et al, 2013). FOXO3’s protective role was also observed in a 
Parkinson’s disease model. Researchers genetically modulated FOXO3 activity and 
determined in vivo that it reduced the accumulation of α-synuclein, an aggregation-prone 
protein, in the adult rat substantia nigra pars compacta (Pino et al, 2014). This protective 
role was also observed in Drosophila, where expression of dfoxo prevented mitochondria 
dysfunction and neuronal degeneration. Similarly, FOXA2 was associated in the loss of 
dopamine neurons observed in Parkinson’s disease. Mice heterozygous for the foxa2 gene 





Studies on FOXO1 showed that this FOX protein influences NPCs fate. In early 
neurogenesis, gain or loss of foxo1 in NPCs prevented and promoted neurogenic 
differentiation in mice, respectively (Hwang et al, 2018). A second study proposed that 
FOXO1’s role in NPC differentiation is through cooperation with the Notch signaling 
pathway (Kim et al, 2015). In addition to functional roles in the CNS, FOXO1 plays a 
role in the peripheral nervous system (PNS). A reduction in sympathetic tone and reduced 
levels of brain-derived norepinephrine were observed after knockout of foxo1 in the PNS 
(Doan et al, 2016).  
In neural signaling, FOXO6 has been associated with memory processing and 
consolidation. Mice lacking foxo6 displayed impaired memory in contextual fear 
conditioning and novel object recognition. In adult wild type mice, a genome-wide study 
showed that foxo6 controls a number of genes that are involved in hippocampal synaptic 
formation. Additionally, foxo6 deficiency results in decreased dendritic spine density 
(Salih et al, 2012). Moreover, FOXO6 has been implicated in axonal guidance and 
cortical migration. Indeed, foxo6 knockout mice showed impaired neuronal migration in 
embryonic day 14.5 neurons. This is in part, because foxo6 influences Plexin A4 
expression, a key component of the semaphorin signaling pathway (Paap et al, 2016). In 
summary, the FOX family of TFs play key roles in brain development, neuron 





1.4 The role forkhead transcription factors in cellular stress response  
As described above, the FOXO TF subclass has neuroprotective roles by 
enhancing antioxidant ability in brain function and development. This function was first 
observed in C. elegans, an effective model system for stress-resistance studies. Dauer 
Formation-16 (DAF-16), FOXO's nematode equivalent, functions as a negative regulator, 
modulating transcription in many genes involved in stress response, metabolism, 
immunity, and longevity. The evolutionary conserved insulin/IGF-1 signaling pathway is 
the main regulator of DAF-16 activity, which increases the lifespan of worms, flies, mice, 
and humans (Holzenberger et al, 2003). When food is scarce, C. elegans adapt by 
entering a ‘dauer’ state, which allows them prolong their lifespan  (Golson & Kaestner, 
2016). DAF-16 in its unphosphorylated state can translocate into the nucleus and activate 
target genes (Kaletsky et al, 2016). Studies have characterized this ‘dauer’ formation by 
an increased resistance to oxidative stress (Ogg et al, 1997; Honda & Honda, 1999). 
Loss-of-function mutations in DAF-16 reduces stress tolerance and are senescence-
deficient (Jia et al, 2004; Tullet et al, 2008). This model also extends to mammals. 
Similar to DAF-16, studies of foxo have been reported to control lifespan in mice under 
restricted calorie intake (Mulvey et al, 2014). Taken together, these results suggest an 
increase in longevity correlates with FOXO’s ability to control oxidative stress resistance 
by enhancing the antioxidant capacity of cells.  
Oxidative stress is an imbalance between ROS production and antioxidant 
defenses. Free oxygen radicals, including superoxide, peroxide, and hydroxyl radical, are 




during cellular respiration in the mitochondria, an intracellular source of oxidant 
production. At homeostasis levels, ROS plays important roles as mediators of in 
physiological processes. For example, low levels of ROS induced by growth factors 
function as signaling messengers to increase cell growth and division.  In stem cell 
renewal, low levels of ROS are needed to signal stem cell proliferation (reviewed in 
Schieber & Chandel, 2014). Moreover, releasing pro-inflammatory cytokines such as 
interleukin-1β, tumor necrosis factor-α, and γ-interferon requires ROS to trigger a cell 
immune response. However, an unbalanced accumulation of ROS can be harmful, 
causing growth arrest and cell death. This duo effect of ROS on cells needs to be 
precisely regulated and redox regulation is therefore essential for maintaining the cell’s 
integrity. FOXO1 plays an important role in preserving redox homeostasis in insulin–
secreting β cells. Exposure of β cells to hydrogen peroxide, a superoxide inducer, 
acetylates FOXO1, resulting in nuclear localization and redistribution, facilitating 
downstream activation of antioxidant enzymes (Kitamura et al, 2005).  FoxO1 protection 
is present during several metabolic stressors, including multiple births, chemical ablation 
of β cells, and leptin receptor deficiency (Kobayashi & Suda, 2012; Golson & Kaestner, 
2016).  
FOXO3 is another TF involved in oxidative stress protection. In human colon 
cancer cells line, Kops and colleagues showed that FOXO3 protected these cells by 
regulating the transcription of an essential antioxidant enzyme, manganese superoxide 
dismutase (MnSOD) (Kops et al, 2002). FOXO3 was also implicated in activating 




fibroblasts (MEFs). Foxo3 knockout in MEFs displayed an accumulation of ROS and a 
reduction in stress resistance (Gurkar et al, 2018). FOXO3 can also protect cells 
undergoing hypoxic conditions. Hypoxia induces the transcription of FOXO3 when 
hypoxia-inducible factor-1α (HIF-1α) binds to FOXO3 promoter. FOXO3 then induces 
Cbp/P300-Interacting Transactivator 2 (CITED2) expression, a transcriptional modulator 
that suppresses Hypoxia-Inducible Factor-1α (HIF-1α) induced apoptosis. This feedback 
loop promotes the survival of cells in response by hypoxia-induced stress (Bakker et al, 
2007). Furthermore, FOXO3 has been characterized as a key molecule in the stress 
network of the endoplasmic reticulum (ER) (Alasiri et al, 2018). Altogether, it appears 
that FOXOs act as molecular switches that determine cell fate in response to different 
levels of stress by promoting antioxidant responses and enhancing pro-apoptotic gene 
expression and cell death.  
Like FOXO proteins, FOXM1 plays an essential role in regulating the cellular 
stress response. Although FOXM1 is best known for its role in controlling cell cycle 
progression (Laoukili et al, 2007), FOXM1 has also been identified as a key regulator of 
ROS in proliferating cells. Park and colleagues observed that FOXM1 induction 
downregulated ROS levels by stimulating the expression of MnSOD, and peroxiredoxin 3 
(PRDX3). Depletion of FOXM1 sensitizes cells to oxidative stress and induces premature 
senescence and apoptosis (Park et al, 2009b). The downregulation of ROS by FOXM1is 
essential for malignant transformation and tumor cell survival. Another study showed that 
FOXM1 is regulated by heat shock factor 1 (HSF1), a stress-inducible TF that is central 




Knockdown or inhibition of HSF1 abolished heat shock-induced expression of FOXM1 
(Dai et al, 2013). Studies have also implicated FOXM1 in modulating the DNA damage 
response and repair in the cell. Foxm1-deficient mouse embryonic cells and human 
osteosarcoma cells depleted of FOXM1 showed an increase in DNA breaks (Tan et al, 
2007). In addition, FOMX1 was observed as an essential transcription regulator of S-
phase kinase-associated protein 2 (Skp2) and cyclin-dependent kinases regulatory 
subunit 1(Cks1), genes crucial for DNA damage recognition (Wang et al, 2005).  
1.5 Forkhead Box R1 (FOXR1)  
Human FOXR1, also known as FOXN5 (forkhead box N5) or DLNB13, is a 292 
amino acid nuclear protein that contains one forkhead domain (Weigel et al., 1989; Katoh 
& Katoh, 2004a). Sequence alignment with all human FOX proteins showed that FOXR1 
is homologous to the FOXN sub-family in the fkh domain, but divergent from other 
members of the FOXN family in the regions outside the fkh domain. Human FOXR1 and 
rat foxr1 gene were found to consist of six exons with conserved exon-intron structure, 
indicating that FOXR1 is well-conserved between human and rat genomes (Katoh & 
Katoh, 2004b). The genome-based tissue expression (GTEx) consortium indicates that 
FOXR1 is expressed in the human brain and reproductive organs (testis and ovary) 
(Consortium, 2013). The human brain transcriptome reveals that FOXR1 is ubiquitously 
expressed in all brain regions during postnatal development and its expression level in the 
brain is maintained throughout life (https://hbatlas.org). Using in situ hybridization, 
mouse foxr1 expression was seen in all brain regions and enhanced within the nucleus, 




We also surveyed mouse foxr1 expression at various tissues at embryonic day 17 (E17) 
and found a 300-fold increase in the brain compared to the heart (Fig 1.3). 
Functionally little is known about FOXR1, but the wide-range expression of 
FOXR1 in most vertebrates indicates its importance. In a genome-wide analysis of the 
expression profile of fox genes, foxr1 was expressed in the gonads of the Nile tilapia, 
Oreochromis niloticus (Yuan et al, 2014b). Foxr1expression was also observed in the 
ovaries of medaka and eel (Geffroy et al, 2016). In mammals, foxr1 RNA was found in 
the male germ cells and spermatids (Petit et al, 2015). In a recent mutagenic study in 
zebra fish (Danio rerio), foxr1 was identified as an important maternal effect gene 
required for cell cycle progression and survival (Cheung et al, 2018). In humans, several 
point mutations within human FOXR1 have been shown to be associated with a variety of 
carcinomas. However, functional characterization of these oncogenic FOXR1 mutants 
has not been carried out (Katoh, 2013; Thackray, 2014). Analysis of the FOXR1 
interactome using STRING analysis in several in vitro cancer cell lines revealed an 
interconnected subnetwork linking FOXR1 to MYC, a TF that acin tivates expression of 
many pro-proliferative genes, and the NuA4/Tip60 histone acetyltransferase complex, 
which is responsible for histone acetylase activity on chromatin. Moreover, Santo and 
colleagues showed that overexpression of FOXR1 is able to substitute for MYC-driven 
proliferation in mouse neuroblasts cells and silencing of FOXR1 in osteosarcoma cells 
resulted in cell cycle arrest and cell death (Santo et al, 2012). Together, these data 




1.6 Individual with a mutation in FOXR1 linked to microcephaly 
The Undiagnosed Disease Network (UDN) of the National Institute of Health 
(NIH) identified an individual presenting with severe neurological symptoms including 
postnatal microcephaly, progressive brain atrophy, and severe muscle hypotonia from 
early infancy. In addition, the individual shows global developmental delays, cerebellar 
hypoplasia, and cerebral white matter atrophy. Brain MRI analysis showed progressive 
hypoplasia in the cerebral cortex, pons and cerebellum and ventricular enlargement from 
age 1 to 5 (Figure 1.4A). Outside of the brain, the individual phenotype included growth 
delay, decreased body weight, short stature, scoliosis, hip dysplasia, ankle clonus and 
bell-shaped thorax (Table 1.1) 
Exome sequencing was performed on DNA from the proband and the siblings and 
parents within the same family who are all relatively healthy. A candidate list of genes 
was produced which underwent multiple rounds of filtering analysis where the UDN 
identified three possible candidates that were likely pathogenic, rapamycin and FKBP12 
target 1 (RAFT1), ATPase Na+/K+ transporting subunit alpha 3 (ATP1A3), and FOXR1. 
RAFT1 functions as a kinase that regulates cell growth, proliferation, motility, and 
survival (Sabatini et al, 1994). A missense homozygous mutation was found within the 
individual’s genome, but further filtering utilizing the EXAC database identified an 
unaffected individual with the same mutation in the RAFT1 gene. The second candidate, 
ATP1A3, which is responsible for establishing and sustaining the electrochemical 
gradients of sodium and potassium ions across the plasma membrane, was also further 




same mutation was discovered and showed mild phenotypes, including learning disability 
and episodes of dizziness. The last candidate, FOXR1, a gene of unknown function, 
revealed a de novo missense mutation in FOXR1 in the individual that is excluded in the 
siblings and parents. The heterozygous de novo nonsynonymous variant results in a 
methionine-to-leucine substitution at position 280 (M280L) and was confirmed by Sanger 
sequencing (Figure 1.4B-C). The M280 lies towards the C-terminal segment of the 
FOXR1 protein, which is outside of the DNA-binding domain (Figure 1.5A). Alignment 
of the FOXR1 C-terminal sequences from mammals, birds, reptiles to frogs and zebrafish 
revealed the M280 is highly conserved through evolution (Figure 1.5B). In addition, the 
M280L mutation in FOXR1 is predicted to be damaging and disease-causing based on 
several web-based applications including Combined Annotation Dependent Depletion 
(score of 29.9 where a score of 30 means that the variant is in the top 0.1% of deleterious 
variants in the human genome; https://cadd.gs.washington.edu), PolyPhen-2 (score: 
0.994/1.0; http://genetics.bwh.harvard.edu/pph2), and Mutation Taster (score: 0.99/1.0; 
http://www.mutationtaster.org). 
1.7 Thesis Rationale  
Neurodevelopmental disorders are due to an abnormal brain development and 
inability to reach cognitive, emotional and motor developmental milestones. Progress in 
genomics has advanced the prognosis of human neurodevelopmental disorders and 
provided insights into the molecular mechanisms of disease (McCarroll & Hyman, 2013). 
While some causal genes are highly penetrant, there are also many rare variants that exist 




function. Through whole-exome sequencing, the Undiagnosed Disease Network (UDN) 
of the NIH identified a mutation in a single allele of the FOXR1 (forkhead box protein 
R1) gene linked to an individual with severe neurological symptoms including postnatal 
microcephaly, progressive brain atrophy and global developmental delays. The 
heterozygous missense mutation in FOXR1 results in a non-synonymous amino acid 
alteration of a conserved methionine at 280 to leucine (M280L) as a potential mutation 
underlying the cause of the rare neurological disease. Therefore, the goal of my thesis is 
to determine the cellular mechanisms underlying FOXR1 function and how the M280L 
mutation leads to disease pathogenesis. Several genes within the FOX family are critical 
for proper neuronal and brain development and overall cellular function. Thus, the results 
from this study will provide new insights into the cellular function of FOXR1 and how a 















Figure 1.1 Transcription factors interact with DNA to promote gene transcription 
Transcription is the first step in gene expression in which DNA is copied into RNA. 
Transcription factors interact with DNA and other regulatory elements to promote and 
enhance transcription by recruiting general transcription factors (TFs) and mediator 





























Figure 1.2 Overview of forkhead transcription factor family  
A, Phylogenetic tree on human FOX family. FOXR1 has highest sequence similarity to 
FOXR2 and the FOXP and FOXN subfamilies and is shown in red box (Adapted from 
Wang et al, 2018a). B, Ribbon representation of the structure of forkhead domain 





Figure 1.3 Expression of human and mouse FOXR1 
Quantitative PCR of mouse embryo tissues at embryonic day 17 (E17) showing robust 















Figure 1.4 Neuroimaging and identification of a de novo FOXR1 missense variant in 
a proband with microcephaly and brain atrophy 
A, Top images, MRI of mid-sagittal images of the proband at 1 and 5 years old showing 
hypoplasia of the pons (arrows) and cerebellum. Bottom images, Horizontal view of the 
proband at 1 and 5 years old showing dilation of ventricle indicated by the arrows. B, 
30 
Pedigree of the family where the letter P in red (black square) indicates the proband. C, 
Sanger sequence analysis confirming the de novo FOXR1 variant. Sequence 
chromatograms demonstrate the presence of the heterozygous variant in the proband, II-4 
(indicated by the red arrow) and the reference allele in both parents and siblings (green 
arrows).  Letters on top indicate amino acid residues (Q = glutamine, C = cysteine, M = 
methionine, L = leucine, S = serine, P = proline). This data was collected by the NIH 
Undiagnosed Diseases Program (NIH UDP): Lynne Wolfe, Christine May Malicdan, 
























Figure 1.5 FOXR1 protein structure and evolution conserved methionine at position 
280 in human. 
A, Schematic representation of FOXR1 protein.  In humans, the primary structure of 
FOXR1 is characterized by a length of 292 amino acid residues. The forkhead (FKH) 
DNA binding domain is located between residues 171 and 265. The human M280L 
mutation identified in an individual with severe neurological symptoms is located on the 
C-terminal end of the protein indicated by the red star. B, Alignment of cross-species 
FOXR1 sequences showing the conserved methionine residue (indicated in red) within a 




CHAPTER 2  
Materials and Methods  
2.1 Exome sequencing 
Exome sequencing was performed at the NIH UDP using genomic DNA extracted from 
peripheral whole blood samples from the study participant and selected family members 
after informed consent onto an institutional review board approved protocol (76-HG-
0238). Exome capture was carried out using manufacturer protocols using the TruSeq 
Exome Enrichment Kit (Illumina, San Diego, CA) and sequenced on the HiSeq 2000 
Sequencing System (Illumina). Alignment to the human genome reference sequence 
(UCSC assembly hg19, NCBI build 37) was carried out using the Efficient Local 
Alignment of Nucleotide Data algorithm (Eland, Illumina, Inc) as described previously 
(Yuan et al, 2014a). Briefly, paired-end (PE) reads were aligned independently and reads 
that aligned uniquely were grouped into genomic sequence intervals of ~100 kb whereas 
reads that failed to align were binned with PE mates without Eland using the PE 
information. Reads that mapped in more than one location were discarded. To align 
binned reads to their respective 100 kb genomic sequence, Crossmatch, a Smith-
Waterman-based local alignment algorithm was used based on the following parameters 
–minscore 21 and  
–masklevel 0 (http://www.phrap.org). Genotypes were identified using a Bayesian 
genotype caller, Most Probable Genotype (Teer et al, 2010). Selected de novo variants 
detected exclusively by exome sequencing were tested by Sanger sequencing. Sanger 




FOXR1 using the following primers F, 5’-AAAGCACTTCCCCTTTTTCC-3’ and R, 5’ 
AGTTGTTTGCCCATGGATTC-3’. 
2.2 Construction of expression vectors 
Full-length human pCMV-SPORT6 FOXR1 plasmid was purchased from GE Dharmacon 
(clone ID 5164198; accession #BC038969). The human M280L mutation in FOXR1 was 
generated by introducing a point mutation at residue 280 (methionine to leucine) using 
QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies) in the pSport6 
human FOXR1 plasmid with the following forward 5’-
CCAACAGTGCTTGAGCCAGCCAG-3’ and reverse 5’- 
ATACTTTCTAGCCGAGTGGAAG-3’ primers and verified by nucleotide sequencing. 
The FOXR1 wild-type and M280L mutant were then PCR amplified using forward 5′- 
AAAGCACTCGAGATGGGGAACGAGCTCTTTCTG-3’ and reverse 5’-
TTTGGCCCGCGGTTAAAGATCAAAGAGGAAGGG-3’ primers and subcloned into 
the XhoI and SacII restriction sites of pEGFP-C3 (Clontech) to create an N-terminal 
EGFP tag. To generate the FOXR1 C-terminal truncation variant, Δ280-292, we used 
full-length human GFP-tagged FOXR1 wild-type as template and designed PCR forward 
5’-AAAGCACTCGAGATGGGGAACGAGC-3’ and reverse 5’-
TTTGGCCCGCGGTTAGCACTGTTGGATACTTTCTAGCCG-3’ primers to amplify 
the region encoding amino acids 1-279, which was subcloned into the XhoI and SacII 




2.3 Cell culture 
HEK 293T (ATCC CRL-3216) and COS-7 (ATCC CRL-1651) cells were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS; Hyclone) and 1% Penicillin/Streptomycin at 37oC in a 5% CO2 incubator. 
Cells at 60% confluency were transfected with GFP, GFP-FOXR1 or GFP-M280L 
plasmids using FuGENE6 transfection reagent (Promega) according to the 
manufacturer’s instructions. For subcellular fractionation, cells were briefly washed with 
phosphate-buffered saline (PBS; 0.137M NaCl, 0.0027 M KCl, 0.01 M Na2HPO4, 
0.0018 M KH2PO4) and lysed in buffer A that consists of 50 mM Tris-HCl pH 7.5, 0.5% 
Triton-X100, 137.5 mM NaCl, 10% glycerol, 5 mM EDTA pH 8.0 with proteinase 
inhibitors. The lysate was centrifuged 850 x g for 15 min at 4°C. The supernatant 
“cytosolic” fraction was removed to a new tube and the remaining “nuclear” pellet was 
washed twice with buffer A at 4°C and centrifuged at 850 x g for 2 min. The pellet was 
then solubilized in buffer B that consists of 50 mM Tris-HCL pH 7.5, 0.5% Triton-X100, 
137.5 mM NaCl, 10% glycerol, 5 mM EDTA pH 8.0, 0.5% SDS with proteinase 
inhibitors (Aprotinin, Sigma Aldrich 10236624001; Leupeptin Sigma Aldrich 
11017101001; Pepstatin Sigma Aldrich 11359053001) and sonicated for 5-10 secs. Equal 
amount of 2x sample buffer (0.1 M Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 10% β-
mercaptoethanol, 0.01% bromophenol blue) was added to the tubes containing the 
nuclear and cytoplasmic fractions, boiled at 100°C for 10 min and subjected to SDS-
PAGE. For MG132 treatment, transfected cells were treated with 50 μM MG132 (Sigma-




Cellular stress paradigms: serum starvation, cells were incubated in DMEM without FBS 
for 24 h at 37oC; for CO2 deprivation, cells were deprived of 5% CO2 for 24 h at 37oC; 
PMA treatment, cells were treated with 1 μM of phorbol 12-myristate 13-acetate (PMA, 
Sigma) for 24 h at 37oC. 
2.4 Western blotting 
Whole cell lysates were extracted from cells in 2x sample buffer (same as above) and 
separated on 10% SDS–PAGE gel and transferred to nitrocellulose membranes (GE 
Healthcare). The membranes were blocked with Odyssey Blocking Buffer in PBS 
(Licor), followed by incubation with primary antibodies against human FOXR1 (Biorbyt, 
1:200), GFP (synaptic systems, 1:1000), GAPDH (EMD Millipore, 1:5000), HSPA1A 
and HSPA6 (Enzo life sciences, 1:1000), DHRS2 (Abcam, 1:500), Histone 3 (Cell-
Signaling, 1:1000) overnight at 4oC. Proteins recognized by the antibodies were detected 
with an Odyssey infrared imaging system (LI-COR) using IRDye680RD- or 
IRDye800CW-coupled secondary antibodies (Goat anti-mouse IRDye 700RD, Goat anti-
rabbit IRDye 800CW 0.5 mg; LI-COR, 1: 20,000).  
2.5 Immunocytochemistry and image analysis 
Transfected cells plated on coverslips were washed briefly with PBS and fixed with 4% 
paraformaldehyde at room temperature for 10 min, permeabilized and blocked in 10% 
goat serum, 0.1% saponin in PBS. To detect oxidative stress following PMA treatment, 
transfected cells were incubated with 5 µM CellROX Oxidative Stress Reagent (Thermo 
Fisher Scientific) for 30 min at 37oC prior to fixation with paraformaldehyde. To detect 




(Enzo Life Sciences). The dye intercalates into the cross-beta spine of quaternary protein 
structures found in misfolded and aggregated proteins. Coverslips were mounted with 
ProLong Gold Anti-fade Mount with DAPI (Fisher Scientific) and imaged with a Carl 
Zeiss LSM700 confocal microscope. Images were collected with identical confocal 
settings for all of the samples and Z-stacked images were projected with maximal 
projection mode using Zeiss Confocal Software.  
2.6 RNA sequencing and analysis 
HEK 293T were transfected with GFP, GFP-FOXR1 or GFP-M280L mutant using 
FuGENE6.  Forty-eight hours after transfection, total RNA was purified using the 
QIAshredder and RNeasy Mini Kit (QIAGEN) and samples were processed with Trizol 
(Invitrogen). Three biological replicates were processed independently. RNA samples 
were suspended in DEPC-treated water and concentrations were determined using the 
Nanodrop ND-1000 (Thermo Scientific) where all samples showed A260/A280 ratios 
higher than 2.0. RNA integrity was also checked in a bioanalyzer (Agilent 2100). Library 
preparations and sequencing were performed by The Broad Institute, Cambridge MA 
using Illumina HiSeq 2000 technology. 
The RNA sequencing analysis was done in collaboration with Dr. Christine 
Chen’s lab at Boston University (Rui Hong & Simon Niu). The RNA sequencing reads 
were aligned to the GRCh38 Homo sapiens genome using HISAT2 (Kim et al., 2019) 
with default parameters. The bam files were sorted by read names instead of chromosome 
coordinates by SAMtools (Li et al, 2009). Gene count matrix of each sample was 




(Anders et al, 2015).  Downstream analysis was performed with the DEseq2 (Love et al, 
2014) package in R. Genes that were not expressed in any cell were removed from 
downstream analysis. Sample PCA plots were generated with ‘plotPCA’ function to 
detect and remove the outlier sample(s) in each condition. Differential expression 
analysis between conditions was performed with the ‘DESeq’ function with default 
parameters. Log-fold change shrinkage was performed on the differential expression 
analysis result. Differentially-expressed genes (DEGs) with adjust-p value < 0.05 and 
log-fold-change > 0.25 were kept for downstream analysis. Heatmaps of DEGs were 
visualized with heatmap and genes with similar expression patterns across samples were 
clustered on the heatmap. Gene set enrichment analysis was conducted with the GSEA 
(Subramanian et al, 2005). Gene ontology (GO) and enrichment analysis encompassing 
the DEGs were analyzed using the Database for Annotation, Visualization, and Integrated 
Discovery (DAVID v6.8) software where the threshold was set as modified Fisher Exact 
P-value (EASE score) < 0.05. 
2.7 Quantitative real-time qPCR analyses 
Total RNA was purified using the QIAshredder and RNeasy Mini Kit (Qiagen). The 
cDNA was synthesized using iScript cDNA Synthesis Kit (Biorad) or Accuris qMax 
cDNA Synthesis Kit (Midland Scientific). Quantitative real-time PCR was performed in 
an ABI Prism 7900HT Fast Real-Time PCR System (Applied Biosystems) using the 
Power SYBR Green PCR Master mix (Thermo Scientific) with a two-step cycling 
protocol and an annealing/extension temperature of 60oC. The experiment was performed 




for each target was normalized using GAPDH as a reference gene and the fold change in 
gene expression was calculated using the ΔΔCt method with the GFP-transfected cells 
serving as control. Primers are listed on table 2.3. Data analysis was performed using the 
ABI Prism 7900HT SDS Software. 
2.8 Dual luciferase assay 
The FOXR1 DNA-binding motif was located by analyzing 3000kb of the upstream 
regulatory region of the of human HSPA1A, HSPA6, and DHRS2 genes. These regions 
were amplified by PCR from genomic DNA and subcloned into pNL3.1-minP/Nluc 
(Promega). Cells were transfected with the normalization plasmid (pGL4.54-LuPrc2/TK; 
Promega), the reporter plasmid (pNL3.1-minP/Nluc) and GFP, GFP-tagged FOXR1, or 
GFP-tagged M280L expression plasmids. Transfected cells were collected in PBS and 
luciferase activity was assessed using the Nano-Glo Dual Luciferase reporter assay 
system (Promega). Dual luciferase signal was quantified using a VICTOR-3 plate reader 
(Perkin Elmer). To control for transfection efficiency, the Nluc reporter plasmid signal 
was normalized to the constitutive luciferase signal (i.e., signal from pGL4.54 plasmid, 
Nluc/Luc2). Fold-induction values for each upstream gene regulatory sequence were 
calculated relative to the background activity of reporter plasmid in the presence of GFP-
FOXR1 or GFP-M280L plasmid. Reporter assays were performed as three biological 
replicates with three technical replicates per biological replicate. For the HSF1 reporter 
assay the upstream transcriptional regulatory region of human FOXR1 was amplified by 
PCR from genomic DNA and subcloned into pNL3.1-minP/Nluc (Promega). Cells were 




plasmid (pNL3.1-minP/Nluc) and GFP-tagged HSF1 expression plasmid. Transfected 
cells were collected and analyzed as detailed above.  
2.9 Detergent extraction assay  
Transfected HEK 293T cells were isolated in 50 mM Tris-HCl buffer at pH 7.5 with 
protease inhibitors by brief sonication and centrifuged at 350,000 x g for 15 min and the 
supernatant was collected as a Tris-HCl soluble fraction. The resulting pellet was 
sequentially extracted (using the same volume) in Tris-HCl buffer containing 1% Triton 
X-100, then by 1% Sarkosyl and finally by 2% SDS. Each detergent extraction step was 
incubated for 1 h at 4oC and centrifuged at 350,000 x g for 15 min, resulting in a Triton 
X-100 soluble fraction, Sarkosyl soluble fraction and SDS soluble fraction, respectively. 
The Tris-HCl fraction containing 20 μg of total proteins, along with equal volumes of 
Triton X-100, Sarkosyl and SDS fractions were loaded onto SDS-PAGE. 
2.10 Primary neuronal cultures and lentiviral infection 
Primary neuronal cultures were prepared from newborn CD-1 mice of either sex. 
Neurons were dissociated with trypsin, triturated, and plated onto coverslips coated with 
Matrigel. After 2 days in vitro (DIV), neurons were infected with lentivirus produced by 
transfecting HEK 293T cells using FuGENE6 (Roche) with plasmids encoding viral 
enzymes and envelope proteins essential for packing of viral particles (RSV/REV, 
MDLg/RRE, and VSVG) with the addition of a shuttle vector encoding GFP-tagged 
FOXR1 WT or M280L mutant. At 14 DIV, neurons were treated with 25 mM KCl for 6 h 
or 25 mM glutamate for 15 min and briefly rinsed with PBS and fixed in 4% 




2.11 Immunoprecipitation  
HEK 293T cells were lysed 48-72 hours following transfection in buffer containing, 20 
mM Tris HCl, 100 mM NaCl, 1 mM EDTA pH 8, and 1% NP-40, supplemented with 
protease/phosphatase inhibitors (Biotool; B15002). Protein extracts were incubated for 2 
hours with rotation at 4° C with the precipitating antibody followed by overnight 
incubation with 25 µl of protein A Ultralink resin (Thermo Scientific). The following day 
the resin was washed 5 times with immunoprecipitation buffer. Precipitated proteins were 
eluted from the resin by boiling for 5 minutes in SDS sample buffer and analyzed by 
electrophoresis. 
2.12 Statistical analysis 
To determine statistical significance, we use either a Student’s t-test to compare two 
groups, or a one-way repeated measures Analysis of variance (ANOVA) for multiple 
comparisons and two-way ANOVA for comparisons with multiple variables. All bars and 
error bars represent the mean + S.E.M. and significance was set at p<0.05. The data were 










Dilution Host Source 
Primary antibodies  
CC3  9661S ICC: 1:1000 Rabbit  Cell Signaling  
BrdU 5292 ICC: 1:2000 Mouse Cell Signaling 
DHRS2  220483 WB: 1:500 Rabbit  Abcam  
FLAG  2220 WB: 1:1000 
IP: 1:500 
Mouse  Sigma-Aldrich  
FOXR1 161065 WB: 1:200 Rabbit  Biorbyt 
GAPDH  MAB374 WB: 1:5000 Mouse  Millipore 
GFP 75-131 WB 1:1000 
IP: 1:500 
Mouse Neuromab 
GFP  132 002 WB 1:1000 Rabbit Synaptic 
Systems 
H3 4499S WB: 1:1000 Rabbit Cell signaling  
HA  9110 WB: 1:1000 Rabbit  Abcam  
HP1α 109028 ICC: 1:500 Rabbit  Abcam  
HSPA1A SPA-810 WB:1:1000 Mouse  Enzo Life 
Sciences 





Ki67 12202 ICC: 1:500 Mouse Cell Signaling 
MAP2  AB5622 ICC: 1:1000 Rabbit Millipore 
PH3  9701 ICC: 1:500 Rabbit Cell Signaling 
PML  96051 ICC: 1:500 Mouse  Abcam  
SC35 11826 ICC: 1:500 Mouse  Abcam  
ZSCAN1 HPA007938 ICC: 1:250  Rabbit  Sigma-Aldrich 























































Kanamycin Clontech Chapters 3-5 
WB, IP, ICC 
P3xFlag-Myc 
 




























































pFUW-FOXR1 WT  pFUW 
 







pFUW-FOXR1 M280L pFUW 
 















Table 2.3 qPCR Primers  




















CHAPTER 3  
Characterization of FOXR1 wild-type and M280L mutation in HEK 293T cells 
3.1 Introduction  
 Forkhead box (Fox) family of transcription factors are highly conserved and play 
essential roles in a wide range of cellular and developmental processes. Fox genes have 
essential biological functions associated with brain development such as FOXG1 
(potential determinant of forebrain size) and FOXP2 (vocal learning). Here, we report an 
individual with severe neurological symptoms including postnatal microcephaly, 
progressive brain atrophy and global developmental delays and implicate a de novo 
heterozygous single amino-acid substitution in FOXR1 (p.M280L) as potentially 
causative. This missense mutation was absent from asymptomatic siblings and parents. 
The M280 lies outside of the FOXR1 DNA-binding domain on the C-terminus and is 
conserved throughout evolution. At the protein level, the M280L impaired FOXR1 
protein expression and induced a nuclear aggregate phenotype in HEK 293T and COS 
cells likely due to protein misfolding making it susceptible to proteolysis and degradation 
through the proteasome pathway.  
 
3.2 Results  
3.2.1 The FOXR1 M280L mutant leads to a decrease in FOXR1 protein expression 
To determine whether the M280L mutation has an effect on FOXR1 expression, 
we generated untagged and N-terminal GFP-tagged FOXR1 mutants bearing the M280L 
mutation within human FOXR1 cDNA by site-directed mutagenesis. We examined 




FOXR1 wild-type (WT) or M280L mutant in HEK 293T or COS7 cells and 
immunoblotting for FOXR1 or GFP-tagged FOXR1 protein. Quantitation showed that 
FOXR1 levels were significantly decreased by the M280L mutation (Figure 3.1). Note 
that, within these experiments, WT and M280L mutant were expressed with identical 
vectors that only differed in the M280L substitution. Since FOXR1 is a transcription 
factor, we next tested whether the M280L mutant affected FOXR1 nuclear distribution in 
HEK 293T cells transfected with plasmids expressing either untagged or GFP-tagged 
FOXR1 WT or M280L by subcellular fractionation. To validate subcellular fractionation 
preparation, isolated cytoplasmic and nuclear fractions were immunoblotted for GAPDH 
(cytoplasmic marker) and histone H3 (nuclear marker). Western blot analysis 
demonstrated that FOXR1 protein expression was present in both cytoplasmic and 
nuclear fractions for FOXR1 WT and M280L with higher expression found in the nuclear 
fraction (Figure 3.2). Also, we found reduced levels of FOXR1 in cells expressing the 
M280L mutant as compared to FOXR1 WT in both cytoplasmic and nuclear fractions 
and the mutant overall did not affect FOXR1 cellular distribution.  
 Next, we investigated whether the decrease in FOXR1 expression in the M280L 
mutant was due to transcriptional or translational changes, we examined FOXR1 RNA 
levels by qPCR and protein stability by proteasome inhibition, respectively. In HEK 
293T-transfected cells, we detected equal amounts of FOXR1 RNA levels encoding 
FOXR1 WT and M280L, indicating that decreased M280L protein expression was not 
due to decreased transcription (Figure 3.3A). To measure protein stability, we blocked 




permeable proteasome inhibitor). Protein levels of both FOXR1 WT and M280L were 
approximately the same after proteasome inhibition, suggesting that the M280L mutant 
destabilizes the FOXR1 protein, likely due to protein misfolding making it susceptible to 
proteolysis and degradation through the proteasome pathway (Figure 3.3B).  
Because the M280 is highly conserved and the M280L mutation led to a 
substantial reduction in FOXR1 protein expression, we wanted to determine whether the 
short C-terminal tail is necessary for protein stabilization. We therefore produced a 
FOXR1 C-terminal truncation mutant lacking the last 12 amino acids from M280 (Δ280-
292) (Figure 3.4A). Indeed, we found that HEK 293T cells transfected with GFP-tagged 
Δ280-292 exhibited decreased protein levels. Similarly, the protein levels were increased 
following MG132 treatment, suggesting that the FOXR1 C-terminal tail is critical for 
FOXR1 protein stability (Figure 3.4B). 
 
3.2.2 FOXR1 M280L mutation induces a nuclear aggregate phenotype 
To examine the cellular localization of FOXR1 WT and M280L, we transfected 
HEK 293T cells with GFP, GFP-tagged FOXR1 WT, M280L or Δ280-292 mutants. 
Immunostaining for GFP showed expression of FOXR1 WT mainly in a diffuse pattern 
in the nucleus co-localized with DAPI nuclear marker (Figure 3.5A). In contrast, about 
13% of cells transfected with the M280L mutant formed discrete nuclear puncta 
phenotype (Figure 3.5A-B). In nuclei containing >15 puncta, the average size of 
individual puncta is <2 µm2, whereas nuclei containing <5 puncta have aggregates of >4 
μm2 (Figure 3.5C-D). In addition, we observe a similar nuclear puncta phenotype in COS 




larger puncta form by coalescing from small nuclear foci. Expression of FOXR1 Δ280-
292 mutant also displayed a similar nuclear puncta pattern suggesting that the nuclear 
puncta phenotype could be misfolded FOXR1 protein that is susceptible to aggregation 
(Figure 3.5A, C).  
To determine whether the nuclear puncta present in M280L mutant-expressing 
cells were toxic to cells and induced apoptosis, we transfected HEK 293T cells with GFP, 
GFP-tagged FOXR1 WT or M280L. We immunostained for cleaved caspase 3 (CC3), a 
crucial mediator of apoptosis, and performed a TUNEL assay, which detects DNA breaks 
in the final phase of apoptosis. Both experiments showed no staining of apoptotic 
markers in cells containing the FOXR1 M280L (Figure 3.7).  Conversely, we wanted to 
determine whether the cells containing the FOXR1 M280L affected the cell cycle and 
immunostained with Ki67 and PH3, which are proliferation markers, and performed a 
BrdU incorporation assay. The cells expressing the M280L mutant did not colocalize 
with the proliferating markers, suggesting it did not impact the mitotic cell cycle (Figure 
3.7).  
Since the FOXR1 M280L mutant puncta were found only in the nucleus, we 
wanted to determine whether they were localized to nuclear bodies. Nuclear bodies are 
dynamic membraneless structures found within the nucleus. These subcellular domains 
are essential to the nuclear landscape because they create distinct environments within the 
nucleus. These structures include nucleoli, Cajal bodies, nuclear speckles, and 
promyelocytic leukemia (PML) bodies (reviewed in Mao et al, 2011). Their function 




spliceosomal components, and DNA repair (Dundr & Misteli, 2010). Notably, nuclear 
bodies have been associated with protein quality control. PML bodies, for instance, can 
act as a stress-responsive compartment, recruiting ubiquitin, chaperones and proteasomes 
to promote misfolded protein degradation (Mediani et al, 2019). To determine whether 
FOXR1 M280L colocalized with nuclear bodies, we expressed the FOXR1 M280L 
mutant in HEK 293T cells. We did not detect any colocalization between markers 
labeling nuclear bodies with the nuclear puncta phenotype observed in the M280L mutant 

















Figure 3.1 FOXR1 M280L mutation leads to a decrease in FOXR1 protein 
expression 
A, Representative immunoblots and quantitative analysis of FOXR1 from HEK 293T 
cells transfected with pCMV-SPORT6 human FOXR1 WT or M280L mutant. GAPDH 
served as a loading control. Graph represents levels of FOXR1 compared to GAPDH and 
normalized to expression of the WT FOXR1. Unpaired t-test (n = 6 independent 
experiments, *** p < 0.0001). B, Representative immunoblot and quantitative analysis of 
FOXR1 from HEK293T cells transfected with GFP, GFP-tagged human FOXR1 WT or 




represents FOXR1 over GAPDH normalized to WT. Unpaired t-test (n = 5 independent 
experiments, *** p < 0.0001). C, Representative immunoblot and quantitative analysis of 
FOXR1 from COS7 cells transfected with GFP, GFP-tagged human FOXR1 WT or 
M280L mutant. GAPDH served as a loading control. Graph represents FOXR1 over 







Figure 3.2 The M280L mutation decreases FOXR1 protein expression in both 
cytoplasmic and nuclear fractions  
Representative immunoblots and quantitative analysis of cytoplasmic (c) and nuclear (n) 
fractions of FOXR1 from HEK 293T cells transfected with pCMV-SPORT6 or GFP-
tagged human FOXR1 WT and M280L. GAPDH and Histone H3 served as cytoplasmic 
and nuclear loading markers, respectively. Graph represents FOXR1 over GAPDH 
normalized to WT. Unpaired t-test (n = 5 independent experiments, *** p < 0.0001). The 












Figure 3.3 FOXR1 M280L mutant is degraded through the proteasomal pathway 
A, Quantitative PCR (qPCR) to quantify FOXR1 RNA levels from HEK293T cells 
transfected with GFP, GFP-tagged human FOXR1 WT or M280L mutant. Graph 
represents relative FOXR1 mRNA expression normalized to GFP (n=3). B, 
Representative immunoblot and quantitative analysis of FOXR1 from HEK293T cells 
transfected with GFP-tagged human FOXR1 WT or M280L mutant. Protein stability was 
monitored by quantitative immunoblotting after blocking with proteasome inhibitor 
MG132. Graph represents FOXR1 over GAPDH normalized to untreated WT. One-way 









Figure 3.4 FOXR1 C-terminal sequence is necessary for protein stabilization 
A Schematic representation of FOXR1 WT and the C-terminal truncation mutant lacking 
the last 12 amino acids, Δ280-292. B, Representative immunoblot and quantitative 
analysis of FOXR1 from HEK293T cells transfected with GFP-tagged human FOXR1 
WT, M280L mutant or FOXR1 C-terminal truncation mutant lacking the last 12 amino 
acids (Δ280-292). Protein stability was monitored for the FOXR1 Δ280-292 mutant by 
blocking with MG132. GAPDH served as a loading control. Graph represents FOXR1 
over GAPDH normalized to untreated WT. One-way ANOVA (n = 3 independent 

































Figure 3.5 The M280L variant induces nuclear aggregate phenotype 
A, Fluorescence images of HEK293T cells transfected with GFP or GFP-tagged human 
FOXR1 WT, M280L or Δ280-292 mutants. DAPI (blue) served as a nuclear marker. 
Scale bar = 20 μm. B, Fluorescence images of HEK 293T cells transfected with GFP-




C, Quantitative analysis of the percentage of cells expressing the FOXR1 puncta 
phenotype. One-way ANOVA (n = 3 independent experiments, **p = 0.0048, *** p = 
0.0002). D, Correlation analysis of the average size of the aggregate to the number of 



















Figure 3.6 The M280L mutation induces a nuclear aggregate phenotype in COS7 
cells 
Fluorescence images of COS7 cells transfected with GFP or GFP-tagged plasmids of 
human FOXR1 wild-type (WT) or M280L. DAPI (blue) served as a nuclear marker. 
Scale bar = 20 µm.  
  
61 
Figure 3.7 Colocalization study of FOXR1 M280L mutant with apoptotic, mitotic 
and nuclear markers  
Representative images of HEK 293T cells transfected pEGFP-tagged M280L mutant 
(green) and immunolabeled with apoptotic (CC3, TUNEL), mitotic (BrdU, Ki67, PH3), 
and nuclear body (HP1α, SC35, PML, ZScan) markers (red). The merge images show the 
green, red, and DAPI (blue) channels together. The nuclear puncta do not appear to 










3.3 Discussion  
 The UDN has identified an individual presenting with postnatal microcephaly and 
progressive brain atrophy and linked a missense variant in the FOXR1 gene as a potential 
mutation underlying the cause of the rare neurodevelopmental disorder. The single de 
novo missense mutation in FOXR1 converts a highly conserved methionine residue at 
amino acid 280 to leucine (M280L). In the present study, we show the M280L variant in 
FOXR1 leads to a robust decrease in FOXR1 protein expression. We observed that the 
protein levels of both FOXR1 WT and M280L are approximately the same after 
proteasome inhibition, suggesting that the M280L mutant destabilizes the FOXR1 
protein, making it susceptible to proteolysis and degradation. In fact, we observed nuclear 
puncta formation in cells expressing the M280L mutant suggesting that the variant leads 
to protein misfolding and aggregation.  Furthermore, truncation of the C-terminus of 
FOXR1 reproduces the M280L mutant phenotype, suggesting that the C-terminal 
sequences of FOXR1 are important for protein stability.  
 Protein function relies on structural stability wherein a three-dimensional fold 
must be adopted and precise protein-protein interaction established. Any alterations that 
negatively affect the native structure or its binding affinity leads to perturbations or 
complete loss of function. Deep sequencing of human exomes mapped out harmful 
mutations enriched in structural categories within ligand binding, active sites, and sites 
participating in hydrogen bonding (Tennessen et al, 2012). These structural elements are 




interactions. Any alterations to these key coding sequences play a major role in the onset 
of various diseases.  
While some causal mutations are highly penetrant, many single-nucleotide 
changes have less severe deleterious effects on gene function (McCarroll & Hyman, 
2013; Tarlungeanu & Novarino, 2018; Parenti et al, 2020). For instance, 
Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome is a disease caused 
by a missense mutation in the p63 gene. P63 is a member of the p53 family of 
transcription factors and is a master regulator of epidermal development (Soares & Zhou, 
2018). The mechanism underlying the pathology of AEC is protein misfolding and 
aggregation, which leads to reduced DNA binding and impaired transcriptional activity of 
the p63 protein (Russo et al, 2018). Blepharophimosis syndrome, which is characterized 
by eyelid malformations, is caused by a mutation in the FOXL2 gene. This mutation leads 
to the expansion of FOXL2’s polyalanine domain, which induces the formation of 
intranuclear aggregates and causes mislocalization of the protein (Caburet et al, 2004). 
Furthermore, a mutation in the FMRP protein, which regulates mRNA metabolism in the 
brain, leads to Fragile X syndrome. The alteration destabilizes the hydrophobic core of 
the FMRP protein causing a partial unfolding and a displacement of alpha-helices (Okray 
et al, 2015). Tay-Sachs, another CNS disease, is also caused by a single point mutation in 
the β-hexosaminidase A (Hex A) lysosomal enzyme. Hex A is necessary for breaking 
down fatty acid substances in brain and nerve cells. When a single base substitution 
impairs this catalytic mechanism, it contributes to the accumulation of fatty acid 




(Myerowitz, 1997). Cystic fibrosis is another disease in which the majority of the 
molecular effects are point mutations in the gene encoding a protein called cystic fibrosis 
transmembrane conductance regulator (CFTR). A missense mutation (a change in a 
valine to an aspartic acid at position 232) causes an aberrant hydrogen bond to form 
between the two transmembrane regions (Loo & Clarke, 2014). This interaction disrupts 
the structure of CFTR, affecting the assembly and overall final shape of the protein, and 
thus the activity of the CFTR protein. Combined, these studies provide examples of 
mutant proteins that lead to protein misfolding and disease pathogenesis. Therefore, any 
alteration, however small, can have negative functional consequences and lead to disease 
pathogenesis.  
 Strict regulation of protein folding and localization is essential for preventing 
disease and maintaining homeostasis (proteostasis). Timely degradation of misfolded 
proteins and their aggregates is also an important element of protein proteostasis. 
Removal of damaged proteins is achieved through various proteolytic pathways, 
including the ubiquitin-proteasome pathway (UPP). The UPP is the main molecular 
mechanism in which eukaryotes control protein degradation. Proteins targeted to 
proteolysis are tagged with an ubiquitin molecule and three enzymatic components (E1, 
E2, E3) are required for this to occur. A large multi-subunit protease complex, called the 
proteasome, recognizes and degrades ubiquitinated proteins. This quality control system 





 It is not surprising that the M280L mutation within FOXR1 affected its 
stabilization since this single de novo missense mutation converted a highly conserved 
residue that was predicted to be damaging and disease-causing on several web-based 
applications. Our observation that the C-terminal truncation mutant reproduced the 
M280L phenotype further suggested that the C-terminus plays a critical role in protein 
stability and is a key structural element for FOXR1. Although the tertiary structure of 
FOXR1 has yet to be reported, the M280L mutation may be disrupting the protein’s 
native hydrogen bonds, thus destabilizing its structure and triggering the puncta 
formation observed. Also, it has been reported that altering hydrogen bond networks can 
affect the conformation flexibility needed for allosteric regulation (Mason et al, 2009). 
Consequently, the M280L variant could be disrupting protein-protein interactions 
occurring in the C-terminal end, which renders FOXR1 unstable and prone to 
degradation. Since protein levels of both FOXR1 WT and M280L were approximately 
the same after proteasome inhibition, this suggests that the M280L mutant is likely 
misfolding and being degraded through the proteasome pathway. In summary, our results 
suggest that the M280L variant in FOXR1 leads to protein destabilization. This finding is 
supported by the decrease in protein expression and the presence of nuclear puncta, 







FOXR1 is a transcription factor that regulates stress-responsive genes 
4.1 Introduction  
 The Fox TF family harbors a core fkh DNA-binding domain that regulates the 
transcription of large array of genes directing major cellular processes. However, outside 
of the conserved fkh domain, Fox TFs display notable functional diversity and have 
evolved distinct roles to regulate specific processes. Currently, little is known about the 
FOXR1 transcriptional regulatory program, how FOXR1 regulates gene expression, and 
how it is affected by the M280L mutation. Here, we identify target genes regulated by 
FOXR1 based on an unbiased transcriptomic screen by RNA-seq in HEK 293T cells 
transiently transfected with GFP, GFP-tagged FOXR1 WT or M280L. Differential 
genome-wide expression analysis between FOXR1 WT transfected cells compared to 
GFP identified 2644 DEGs of which 49.7% were upregulated and 50.3% were 
downregulated transcripts, suggesting that FOXR1 acts as both a transcriptional activator 
and repressor. We paid special attention to those DEGs that differ between FOXR1 WT 
and M280L. The most significantly upregulated genes in response to FOXR1 WT and 
significantly less upregulated by M280L compared to the control included two members 
of the Hsp70 family of heat shock proteins (HSPs) (HSPA1A, HSPA6) and a 
mitochondrial reductase enzyme, DHRS2. Each of these proteins play a role in protecting 
against oxidative stress-mediated cellular response. We validated and quantified the 
transcript levels of FOXR1-regulated genes by qRT-PCR and found agreement between 




HSPA6, HSPA1A and DHRS2 contain FOXR1 response elements within their 
transcriptional regulatory regions and show that they are direct targets of FOXR1 and the 
M280L mutation within FOXR1 abolishes its ability to activate the expression of these 
target genes. Moreover, we observed FOXR1 promoter activation by HSF1, the primary 
mediator of cell stress response.  
4.2 Results 
4.2.1 Identification of novel FOXR1-dependent transcripts by RNA sequencing 
analysis  
To identify target genes regulated by FOXR1 and to investigate the role of 
FOXR1 M280L mutant, we performed an unbiased transcriptomic screen by RNA 
sequencing (RNA-seq) in HEK 293T cells transiently transfected with GFP, GFP-tagged 
FOXR1 WT or M280L for 48 hours. Principal component analysis was used to analyze 
the relationship between samples and showed the three groups clustered separately 
excluding experimental covariates and batch effects (Figure 4.1A). Differential genome-
wide expression analysis between FOXR1 WT transfected cells compared to GFP 
identified 2644 DEGs of which 1315 (49.7%) were upregulated and 1329 (50.3%) were 
downregulated transcripts, suggesting that FOXR1 acts as both a transcriptional activator 
and repressor (Figure 4.1 B). Interestingly, when we compared M280L to WT, we 
identified 735 DEGs of which 561 (76.3%) were upregulated and 174 (23.7%) genes 
were downregulated (Figure 4.1B). We plotted a heat map of the log (2) fold change for 
all the differentially-expressed genes (DEGs) and delineated five coherent clusters 




paid special attention to those transcripts whose levels showed a 2-fold increase in the 
FOXR1 WT-expressing cells and a significantly lower increase in the FOXR1 M280L-
expressing cells relative to the GFP control, as delineated in cluster E (Figure 4.2B).  
Gene ontology (GO) analysis for biological processes within cluster E showed 
that genes involved in the heat shock response, which is functionally-related to negative 
regulation of inclusion body assembly, chaperone cofactor-dependent protein refolding, 
de novo protein folding, cellular response to stress and regulation of HSF1-mediated heat 
shock response, were enriched in the cluster of genes upregulated by FOXR1 WT with 
diminished upregulation by FOXR1 M280L (Figure 4.3 and 4.4). Based on the volcano 
plots that summarizes both the expression fold-change and the statistical significance, the 
upregulated genes in response to FOXR1 WT and a diminished upregulation in M280L 
included HSPA1A and HSPA6 (both members of the Hsp70 family of heat shock 
proteins), and DHRS2 (Dehydrogenase/Reductase SDR Family Member 2, a 
mitochondrial reductase enzyme) (Figure 4.5). Each of these proteins play roles in 
protecting against oxidative stress-mediated cellular response.  
We next validated and quantified the transcript levels by quantitative real-time-
PCR (qRT-PCR) and found agreement between the RNA-seq and qRT-PCR data for 
HSPA6, HSAPA1A and DHRS2 using specific primers (Fig 4.6). The qRT-PCR data 
confirmed the upregulation of gene expression for HSPA6, HSAPA1A and DHRS2 that 
were exclusively upregulated in FOXR1 WT and not in M280L mutant. When we 
analyzed some of the other heat shock proteins such as SACS, DNAJC21 and DNAJC6, 




In addition, not all members of the Hsp70 family of heat shock proteins were 
misregulated in the M280L mutant. For example, the HSPA12A transcript was 
upregulated in both FOXR1 WT and M280L. These results indicate that FOXR1 drives 
expression of specific heat shock chaperone proteins and an important NADPH-
dependent reductase enzyme that is likely related to cytoprotective pathways alleviating 
oxidative stress. 
 
4.2.2 FOXR1 controls gene expression of heat shock chaperone and an anti-oxidant 
NADPH-dependent reductase transcripts 
To determine whether HSPA6, HSPA1A and DHRS2 are directly regulated by 
FOXR1 as opposed to secondary targets of FOXR1, we performed a de novo motif 
analysis of target upstream regulatory regions to identify consensus DNA-binding sites. 
We found strong consensus sequences for FOXR1 response elements (Nakagawa et al., 
2013) within the upstream regions of at least three of the top FOXR1-regulated genes, 
HSPA6, HSPA1A and DHRS2 (Fig 4.7A). To determine whether FOXR1 expression 
regulates the activity of these regulatory regions, a dual luciferase system under the 
control of proximal upstream regions of human HSPA6 (-1119 to -113 bp), HSPA1A (-
1053 to -210 bp) and DHRS2 (-3329 to -2313 bp) was co-transfected with either GFP 
control, GFP-FOXR1 WT or GFP-M280L mutant in HEK293T cells (Fig 4.7B). We 
found that HSPA6, HSPA1A and DHRS2 were activated by FOXR1 WT but not by 
M280L, suggesting that these upstream regulatory regions contain FOXR1 responsive 




in the M280L mutant is likely due to the decrease in FOXR1 expression levels and 
possibly protein misfolding. (Fig 4.7C).  
Expression of HSPs is known to be regulated by the transcription factor heat 
shock factor 1 (HSF1), which has a high affinity for cis-acting DNA sequence elements, 
including the heat shock elements (HSEs) found in the promoters of HSF-responsive 
genes such as Hsp70 proteins (reviewed in Akerfelt et al, 2010). There is also precedence 
that HSF1 target genes extend beyond molecular chaperones. For example, in C. elegans, 
the protective effects of reduced insulin signaling require both HSF1 and the FOXO 
transcription factor, DAF-16, to prevent damage by protein misfolding and to promote 
longevity (Hsu et al, 2003; Morley & Morimoto, 2004; Singh & Aballay, 2009). Based 
on the GO analysis for biological processes, transcripts that were upregulated in FOXR1-
transfected cells were genes related to regulation of HSF1-mediated heat shock response 
(Figure 4.3). Hence, we searched for and identified FOXR1 response elements upstream 
of the HSEs in both the HSPA6 and HSPA1A upstream regulatory sequences (Appendix 
figure 3.1). We also identified a consensus sequence for binding by HSF1 within the 
promoter region of FOXR1. Utilizing a dual luciferase system under the control of an 
upstream region of human FOXR1 (-633 to +1 bp), FOXR1 was found to be activated by 
HSF1. However, HSF1-mediated FOXR1 activation was not observed when the HSF 
response element was mutated from TTCTAGAA to GGCTAGAA in vitro, suggesting 
that human FOXR1 is a direct target of HSF1, which may be regulated by cellular stress 











Figure 4.1 Gene expression profiling by RNA-seq 
A, PCA plot of the three groups clustered separately in multidimensional scaling 
analyses. Groups of samples analyzed using Principal Component Analysis (PCA) plots 
where replicates are clustered together and clusters from different conditions are 
separated. B, Pie chart showing the distribution of 2644 differentially-expressed genes 
between GFP and FOXR1 WT and 735 differentially-expressed genes between FOXR1 
WT and M280L.  
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Figure 4.2 Heat map for hierarchical cluster analysis of DEGs between samples 
A, Heatmap of hierarchical clustering indicates differentially-expressed genes (rows) 
between GFP, GFP-tagged FOXR1WT and M280L (fold-change > 2, p < 0.05). Red 
indicates up-regulated genes and blue indicates down-regulated genes. B, Heatmap of 
gene cluster ‘E’ of differentially-expressed genes (rows) that are upregulated in FOXR1 




Figure 4.3 Gene ontology (GO) enrichment analysis between GFP control and 
FOXR1 WT 
Normalized enrichment scores indicate the distribution of biological processes across the 
indicated lists of genes ranked by hypergeometrical score. Higher enrichment scores 
indicate a shift of genes belonging to certain GO categories towards either end of the 
ranked list, representing up or down-regulation (positive or negative values, 
respectively).  
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Figure 4.4 Gene ontology (GO) enrichment analysis between FOXR1 WT and 
FOXR1 M280L mutant 
Normalized enrichment scores indicate the distribution of biological processes across the 
indicated lists of genes ranked by hypergeometrical score. Higher enrichment scores 
indicate a shift of genes belonging to certain GO categories towards either end of the 
ranked list, representing up or down-regulation (positive or negative values, 
respectively).  
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Figure 4.5 Top differentially expressed genes regulated by FOXR1 
A, Volcano plot of differentially expressed genes that were up-regulated between 
FOXR1 WT versus GFP control. Significantly up-regulated genes are in red while down-
regulated genes are in blue. Non-significant genes are in gray. B. Volcano plot of 
differentially expressed genes that were down-regulated between FOXR1 M280L versus 
WT. Significantly down-regulated genes are in blue and up-regulated are in red. Non-
significant genes are in gray. C. Heatmap of gene cluster ‘E’ highlighting several 
chaperone proteins that were differentially expressed in the FOXR1 WT dataset but 




















Figure 4.6 Verification of top RNA-seq differentially expressing genes 
Quantitative real-time PCR verifying the RNAseq analysis showing that FOXR1 drives 
expression of HSPA6, HSPA1A and DHRS2 and that expression of these genes is 
misregulated in the M280L mutant. Graphs represent relative expression normalized to 
levels of expression of each gene in the GFP control samples. One-way ANOVA (n = 3 








Figure 4.7 Human DNA binding-site motifs predicted to be bound by FOXR1 
A, FOXR1 response elements showing consensus primary and secondary sequences 
bound by FOXR1 (adapted from Nakagawa et al., 2013). B, Putative FOXR1 response 
elements are denoted in the upstream regulatory regions of three of the top-regulated 
FOXR1-targeted genes: HSPA6, HSPA1A and DHRS2. C, Dual luciferase reporter assays 
where GFP control, GFP-FOXR1 WT or GFP-M280L were co-transfected into HEK 




Data are plotted as luciferase activity normalized to GFP control. One-way ANOVA (n = 

















Figure 4.8 FOXR1 is regulated by HSF1  
Consensus primary sequences bound by HSF1. The putative HSF1 response elements are 
denoted in the promoter of FOXR1. Dual luciferase reporter assays in HEK 293T cells 
comparing FOXR1 promoter activation to a FOXR1 mutant where two residues of the 
HSF1 response elements in FOXR1 were mutated from TT to GG (mutant). Data was 
plotted as luciferase activity normalized to GFP control. One-way ANOVA (n = 3 




 4.3 Discussion  
In the present study, we show that FOXR1 is likely to be both a transcriptional 
activator and a repressor. We found that two heat shock proteins, HSPA1A and HSPA6, 
and a reductase enzyme, DHRS2, known to protect cells against stress, were upregulated 
in response to FOXR1 WT and less upregulated in M280L. Overall, several additional 
chaperone proteins were found to be upregulated with FOXR1 WT and lowly expressed 
in the GFP control and the FOXR1 M280L mutant. Results from luciferase activity 
assays indicated that FOXR1 induces HSPA1A, HSPA6, and DHRS2 expression, while 
FOXR1 M280L mutant does not under the conditions of transfecting the same amount of 
expression plasmid. Additionally, we were able to show that FOXR1 can be induced by 
HSF1, an integrator of transcriptional responses during stress. Taken together, our results 
suggest that FOXR1 is a regulator of the stress response in HEK 293T cells.  
HSPs are evolutionarily conserved proteins that play crucial roles in protein 
maturation, stabilization, folding, and degradation. Many HSPs are continuously 
expressed, while others are inducible and only upregulated by stress. Additionally, HSPs 
may promote the ubiquitination of misfolded proteins, which targets them for degradation 
through the UPP (reviewed in Whitley et al, 1999). The term ‘heat shock’ is a misnomer 
since these proteins are induced by a variety of environmental and metabolic stress 
stimuli. HSPs are classified into two families based on size, small and large ATP-
depending HSPs. The most well-known chaperones are part of the large family and 
include HSP90 and HSP70. Other large HSPs include HSP40s and J-proteins, which 




2018). The ability of FOXR1 to induce the expression of specific chaperone proteins 
suggests it plays an important role in providing the cell tolerance against sustained stress 
stimuli.   
Although DHRS2 has not been characterized as a chaperone in cells, this protein 
was reported to be associated with oxidative stress. DHRS2 is part of the short-chain 
dehydrogenase/reductase (SDR) superfamily of reductases known for their specificity for 
reactive dicarbonyl compounds (Hoffmann & Maser, 2007). This family is involved in 
the reductive metabolism of cytotoxic secondary products found in cells during oxidative 
stress. Notably, DHRS2 localizes to mitochondria, indicating a physiological role 
associated with oxidative stress. Indeed, DHRS2 was shown to catalyze the NADPH-
dependent reduction of dicarbonyl compounds with similar turnover numbers as DCXR, 
a mitochondrial dicarbonyl reductase (Shafqat et al, 2006). Functional studies have 
demonstrated a protective role of DHRS2 against apoptosis induced by oxidative stress. 
Zhou and colleagues showed a significant reduction in ROS presence in a human 
esophageal squamous carcinoma cell line expressing DHRS2 (Zhou et al, 2018). Further 
analysis showed that DNA lesions resulting from ROS were decreased in DHRS2 
expressing cells. Another study by Monge and colleagues using specific siRNA showed 
that DHRS2 was able to alleviate oxidative stress and associated cell damage (Monge et 
al, 2009). As such, it is likely that FOXR1’s induction of DHRS2 upon stress functions to 
protect the cell from the harmful effects of dicarbonyl compounds.  
Although DHRS2's protective function in the brain remains unclear, this SDR 




is a class of neurodegenerative diseases characterized by frontal and temporal lobe 
degeneration that results in early-onset dementia. DHRS2 was shown to be 
downregulated in neurons that were co-cultured with FTD astrocytes derived from an 
FTD individual (Hallmann et al, 2017). From this finding it can be inferred that the 
decrease in DHRS2 expression likely reduced the ability of neurons to clear reactive 
compounds produced as a consequence of metabolic or oxidative stress, thus, making the 
neuron susceptible to neurodegeneration. 
Various studies have indicated the presence of HSPs in the brain and their defined 
spatio-temporal expression patterns suggest these proteins have distinct roles during 
development. There is also growing evidence that HSPs facilitate and inhibit 
neurodevelopment by means of cell differentiation, neurite outgrowth, cell migration, or 
angiogenesis. (reviewed in Miller & Fort, 2018). The presence of HSPs is crucial for 
neuronal and glial progenitor cell survival since normal mammalian development occurs 
in a relatively hypoxic environment (Majmundar et al, 2010). Walsh and colleagues 
showed that the expression of HSPs is strictly modulated in early embryogenesis. 
Specifically, the presence of Hsp70 in mouse brains correlated with proper cell cycle 
progression (Walsh et al, 1997).  Also, Hsp70 has been implicated as a potential 
contributor to cellular migration. Neuroblast cells treated with Hsp70 inhibitors hindered 
regular migration from the subventricular zone (Miyakoshi et al, 2017). Taken together, 
these studies show the wide range of roles Hsp70 plays during development.  
It is well-established that HSF1 is the master regulator of the stress response. This 




shock elements within the promoter regions of molecular chaperones (Nollen & 
Morimoto, 2002). HSF1 has also been implicated in the regulation of various cellular 
processes, including cell proliferation, inflammation, and energy metabolism. In addition, 
HSF1 has been linked to proper brain development. Notably, the HSF1 response to 
cellular stress is deficient in mature neurons in the adult brain (Morimoto, 2008), but 
rather strong in the embryonic brain. Activation of HSF1 promotes transcription of 
synaptic proteins (PSD95, SAP97), forming essential synaptic elements—neuroligins, 
vesicle transport, synaptic scaffolding proteins, lipid rafts, synaptic spines, and 
axodendritic synapses (Hooper et al, 2016). It is important to note that while HSF1 is 
overexpressed in many cancers, the opposite is observed in neurodegenerative diseases, 
leading to neuron death from unfolded protein response. In hsf1 null mice, impaired 
olfactory neurogenesis, as well as hippocampal spinogenesis, was observed (Takaki et al, 
2006; Uchida et al, 2011). Another study in hsf1 null mice showed progressive myelin 
loss that accompanied severe astrogliosis, an increase in astrocytes due to CNS trauma 
(Homma et al, 2007).  Also, high levels of ubiquitinated proteins and protein oxidation 
were observed in hsf1 null brain (Yan et al, 2002). When investigating the role of HSF1 
in neurodevelopment disorders, Hashimoto-Torii and colleagues exposed hsf1 knockout 
mice embryos to stress. Following their birth, they observed cortical malformations and a 
reduction in brain size (Hashimoto-Torii et al, 2014).  Studies in cell culture, fruit fly, 
worm, and mouse models of neurodegenerative disease demonstrate that enhancing 
protein-folding capacity via elevated expression of HSF1 has therapeutic potential, 




expression in the brain leads to a decrease in the quality control mechanisms, thereby 
contributing to neuronal dysfunction, disease progression, and cell death.   
Cells respond to environmental stressors though the activation of specific 
physiological pathways that increase the abundance or activity of chaperone proteins 
which prevent protein misfolding to protect the proteome and maintain proteostasis 
(Voellmy, 1994; Grune et al, 2004; Scandalios, 2005; Raynes et al, 2016). Studies have 
shown that Fox transcription factors can induce the expression of HSPs. For example, the 
FOXO subfamily of transcription factors play an important role in protecting organisms 
against stress (Kops et al., 2002; Bakker et al., 2007; Eijkelenboom et al, 2013). The 
FOXO genes present in Drosophila (dFOXO) and in C. elegans (DAF16) are 
transcriptional activators of Hsp70 genes that contribute to proteostasis maintenance in 
response to oxidative stress. DAF16 maintains proteostasis in C. elegans by 
transcriptionally increasing a subset of small Hsp genes that is important in DAF-16 
dependent lifespan extension (Hsu et al., 2003; Murphy et al, 2003). Consistent with C. 
elegans, Drosophila dFOXO also induces transcription of Hsp genes in response to 
oxidative stress resistance (Donovan & Marr, 2016). FOXO3 and FOXM1 orchestrate 
gene expression programs that control resistance to oxidative stress by upregulating 
catalase and MnSOD, enzymes involved in the detoxification of reactive oxygen species. 
(Kops et al., 2002; Bakker et al., 2007; Park et al, 2009a; Gurkar et al., 2018). 
Disturbances in the ability of the cell to respond to stress increases the 
susceptibility to cell degeneration. Thus, the inability of FOXR1 M280L to induce the 




observed in the individual. As a downstream target of HSF1, FOXR1 likely plays a role 
in protecting the proteome and aiding cell survival. Without the FOXR1-induced 
activation of HSPs and DHRS2, especially during development when cellular metabolism 
and energy production is high, cells become susceptible to injury and prone to cell death. 
Together, these results represent the first demonstration of FOXR1 function as a possible 
stress-responsive protein. Elucidating the pathways that integrate the cellular stress 









FOXR1 mediates cellular stress response 
5.1 Introduction  
 Forkhead TFs are critical mediators of the cellular stress response. This role has 
been well categorized in the FOXO subclass. Members of this family are known to 
induce a program of gene expression associated in the DNA-damage response in cells 
under stress. FOXOs ability to mediate DNA repair correlates an increased in longevity 
in mammals (Kops et al., 2002; Donovan & Marr, 2016; Gurkar et al., 2018; Hwang et 
al., 2018). FOXR1’s ability to induce the expression of stress response genes suggests 
that this forkhead TF is involved in cellular stress response. Here, we show that FOXR1 
protein expression increased 2-fold during metabolic and oxidative stress. Under 
oxidative stress, we observe an increase in puncta formation in the nucleus of cells 
expressing the FOXR1 M280L mutant. When cells treated with phorbol 12-myristate 13-
acetate (PMA), an enhancer of reactive oxygen species (ROS), we observed an increase 
in both HSPA6 and DHRS2 protein expression levels in cells transfected with FOXR1 
WT. We also characterize the nuclear puncta formation in cells expressing the M280L 
mutant as aggresomes through colocalization analysis with a protein aggregation 
detection dye and through solubility studies.  
5.2 Results 
5.2.1 FOXR1 expression in increased in response to cellular stress 
Because FOXR1 regulates expression of HSPA6, HSPA1A and DHRS2 




following stress-induced paradigms. To test this, we induced cellular stress using 
different paradigms: serum deprivation (metabolic stress for 24 hours) and CO2-
deprivation (oxidative stress for 24 hours). In both stress-induced paradigms, cells 
transfected with the GFP-FOXR1 WT expression plasmid demonstrated a 2-fold increase 
in protein expression when compared to the non-stressed conditions (Figure 5.1A). In 
contrast, GFP-FOXR1 M280L expression was increased under CO2-deprivation but not 
in serum-deprivation. Fluorescence images of HEK 293T cells shows an increase in 
number of cells with puncta formation in CO2-deprived cells expressing the FOXR1 
M280L mutant indicating that the M280L mutant may be sensitive to different types of 
environmental stressors (Figure 5.1B).  
To further explore the relationship between FOXR1 and oxidative stress, we 
treated FOXR1-transfected HEK 293T cells with phorbol 12-myristate 13-acetate (PMA), 
a pharmacologic NADPH oxidase activator known to enhance reactive oxygen species 
(ROS) generation through a protein kinase C-mediated pathway (Figure 5.2A) (Bhat et 
al, 2019). We assessed ROS generation by fluorescence imaging using CellROX, a 
photostable ROS sensor. Consistent with other stress paradigms, PMA enhanced ROS 
generation in HEK 293T cells transfected with FOXR1 WT and M280L (Figure 5.2B). 
PMA increased FOXR1 expression in the nucleus of HEK 293T cells transfected with 
FOXR1 WT while we found an increase in the number of nuclear aggregates per cell in 
cells transfected with the M280L mutant suggesting that ROS induced aggregation of 
FOXR1 mutant protein in response to stress. In fact, both CO2-deprivation and PMA 




mutant due to elevated expression. To determine whether ROS-induced aggregation of 
FOXR1 protein is cytotoxic, we measured the amount of lactate dehydrogenase (LDH) 
released into the medium as a measurement of cytotoxicity and found no LDH changes 
across cells transfected with GFP alone, GFP-tagged FOXR1 WT or M280L indicating 
that cells expressing FOXR1 WT and M280L, which contained nuclear aggregates were 
not cytotoxic (Figure 5.2C).  
In the presence of PMA, we found FOXR1 protein expression was increased over 
2-fold in cells transfected with FOXR1 WT and M280L mutant after PMA treatment. 
Concomitantly, we found an increase in DHRS2 protein expression levels only in cells 
transfected with FOXR1 WT (Figure 5.3) suggesting that FOXR1 is likely related to 
cytoprotective pathways alleviating oxidative stress. In contrast, we did not observe any 
changes in HSPA6 and DHRS2 protein expression levels in cells transfected with M280L 
regardless of PMA treatment. In addition, while we observe a significant increase in 
HSPA1A mRNA levels in cells transfected with FOXR1 WT, we did not detect any 
changes in HSPA1A protein levels in cells transfected with FOXR1 WT or M280L. 
However, we did consistently see a decrease in HSPA1A protein levels in cells 
transfected with M280L compared to FOXR1 WT in the presence of PMA.  
5.2.2 FOXR1 nuclear aggregates in M280L mutant are insoluble protein aggregates 
To determine whether the nuclear puncta that form in HEK 293T cells transfected 
with M280L mutant were aggresomes which are known to serve as storage bins of 
misfolded or aggregated proteins, we transfected HEK 293T cells and treated with PMA 




aggregated proteins in cells (Shen et al, 2011).  We found bright punctate staining for 
proteostat-positive aggregates colocalized with the nuclear puncta in cells expressing the 
M280L mutant but not in FOXR1 WT (Figure 5.4A). These results were similar with 
transfected cells expressing M280L that were treated with cell-permeable proteasome 
inhibitor MG132 which further supports that the M280L mutation destabilizes the 
FOXR1 protein and causes formation of nuclear aggregates (Figure 5.4B).  
 Misfolded proteins often expose their hydrophobic domains which leads to 
aggregation (Kim et al, 2013; Diaz-Villanueva et al, 2015). In addition, most aggregated 
proteins tend to coalesce and form large deposits such as aggresomes or inclusion bodies 
(Kopito, 2000). Previous studies have shown nuclear and cytoplasmic aggregates of poly-
Q proteins such as ataxin-1 are dynamic and exchange their components whereas ataxin-3 
nuclear foci are immobile (Kim et al, 2002; Stenoien et al, 2002). We therefore used 
time-lapse imaging of live cells to determine whether nuclear aggregates from HEK 293T 
cells transfected with GFP-tagged M280L were dynamic and mobile. Live-cell imaging 
showed the nuclear aggregates are quite dynamic and undergo extensive movements and 
fusions, whereas small aggregates move toward each other and fuse to form larger 
aggregates (Figure 5.4C). 
 Another criteria of misfolded proteins deposited within aggresomes is that they 
are largely detergent insoluble (Ward et al, 1995; Scherzinger et al, 1997; Garcia-Mata et 
al, 1999; Kopito, 2000). Thus, we examined the biochemical properties of M280L 
aggregates versus FOXR1 WT, in which protein lysates from HEK 293T cells transfected 




detergents. Protein extracts were sequentially extracted by Tris-HCl buffer, by Tris-HCl 
buffer containing 1% Triton-X100, by 1% Sarkosyl and finally by 2% SDS (Figure 
5.5A). The amount of GFP-FOXR1 extracted in each fraction was assessed by 
immunoblotting for GFP-FOXR1. GFP-FOXR1 WT was detected in Tris-HCl soluble, 
sarkosyl soluble and SDS soluble fractions but not present in the Triton X-100 soluble 
fraction, suggesting that the majority of the FOXR1 WT protein are mostly soluble, in 
oligomeric form not associated with membrane-bound proteins (Figure 5.5B). However, 
the majority of M280L was detected in the SDS fraction indicating a significant portion 
of the protein is aggregating which correlates with the increased aggregation shown by 







Figure 5.1 FOXR1 protein expression is increased in response to cellular stress  
A, Representative immunoblots and quantitative analysis for FOXR1 from HEK 293T 
cells transfected with GFP, GFP-tagged FOXR1 WT or M280L mutant in response to 
serum and CO2 deprivation. GAPDH served as loading control. Graph represents FOXR1 
over GAPDH normalized to untreated WT. One-way ANOVA (n = 4 independent 
experiments, ** p <0.005). B, Fluorescence images of HEK 293T cells transfected with 
GFP-tagged human FOXR1 WT or M280L in response to serum and CO2 deprivation. 





Figure 5.2 PMA induces nuclear puncta formation in FOXR1 M280L mutant  
A, Schematic summary of signal transduction by phorbol 12-myristate 13-acetate (PMA). 
PMA directly binds to PKC, resulting in activation of NADPH-oxidase, which is 
responsible for the generation of reactive oxygen species (ROS). B, Fluorescence images 
of HEK 293T cells transfected with GFP-tagged human FOXR1 WT or M280L and 
treated with PMA. Cells were fixed after 24 hours of treatment and assessed for ROS 
generation using CellROX, a photostable ROS sensor. Scale bar = 20 μm. C, Cell 
viability assay performed by the lactate dehydrogenase (LDH) assay to analyze 








































Figure 5.3 Protein expression of FOXR1 and the FOXR1 DHRS2 target gene  
A, Representative immunoblots and quantitative analysis of HEK293T cells following 
PMA treatment showing an increase in FOXR1 expression. Graph represents FOXR1 
over GAPDH normalized to untreated WT. One-way ANOVA (n = 5 independent 




and DHRS2 protein levels from HEK293T cells transfected with GFP, and GFP-tagged 
human FOXR1 WT or M280L. Graph represents expression levels of protein of interest 
over GAPDH, normalized to the GFP-expressing sample. One-way ANOVA (n = 4-6 
independent experiments, * p < 0.05, ** p<0.005). C, Quantitative analysis of HSPA6, 
HSPA1A and DHRS2 protein levels from HEK293T cells transfected with GFP, GFP-
tagged human FOXR1 WT or M280L and treated with PMA. Graph represents protein of 
interest over GAPDH normalized to GFP. One-way ANOVA (n = 2-3 independent 








Figure 5.4 GFP-FOXR1 M280L co-localized with Proteostat dye that recognizes 
misfolded proteins 
97 
A, Fluorescence images of HEK293T cells transfected with GFP-tagged human FOXR1 
WT or M280L and treated with PMA. Cells were fixed after 24 hours of treatment and 
stained with Proteostat marker. White square boxes in the middle panels indicate images 
presented in the bottom panel at higher magnification. Top and middle panels, scale bar = 
20 m. Bottom panels, scale bar = 10 μm. B, Fluorescence images of HEK293T cells 
transfected with GFP-tagged M280L and treated with MG132. Cells were fixed after 24 
hours of treatment and immunolabelled with Proteostat marker. Scale bar = 10 µm. C, 
Time-lapse imaging of HEK293T cells transfected with GFP-tagged M280L. Top panel 
represents images showing nuclear aggregates undergoing extensive movements and 
fusions. Bottom panel illustrates schematic drawings of the fusion events. Scale bar = 5 
μm. 
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Figure 5.5 M280L nuclear aggregates are insoluble misfolded proteins 
A, Schematic chart of the detergent fractionation assay. B, FOXR1 proteins were 
sequentially extracted with Tris-HCl, Triton X-100, Sarkosyl and SDS in this order. 
Quantification shows that the amount of FOXR1 in the SDS fraction was significantly 
higher in the M280L mutant when compared to the overall Tris-HCl total fraction. One-




5.3 Discussion  
 Fox TFs play important roles in protecting cells against stress.  In the present 
study, we show that FOXR1 protein expression is increased during metabolic (serum 
starvation) and oxidative stress (CO2 deprivation, PMA treatment). The increase observed 
in FOXR1 WT expression under PMA treatment correlates with an increase in protein 
expression levels of DHRS2. Although we did not see a significant change in HSPA1A 
protein expression, we have previously shown an increase in mRNA levels in cells 
transfected with FOXR1 WT. In contrast, we did not observe changes in HSPA6 and 
DHRS2 proteins levels in cells transfected with the M280L mutant, regardless of stress. 
Under oxidative stress conditions, protein levels of both FOXR1 WT and M280L mutant 
were approximately the same; however, further analysis demonstrated that the 
upregulation in M280L mutant protein was due to an increase in puncta formation in the 
nucleus that were not cytotoxic.  We found the nuclear puncta colocalized with the 
Proteostat dye, an agent that becomes brightly fluorescent upon binding to aggregated 
proteins. We also showed that a significant portion of the M280L mutant protein was 
detected in the high detergent fraction, further indicating the nuclear puncta are indeed 
protein aggregates. Taken together, our results suggest that FOXR1 is related to 
cytoprotective pathways that enable the cell to cope with stress.  
 Various human diseases are associated with protein misfolding and aggregation. 
Misfolded proteins are detrimental to the cell, and the nucleus is especially susceptible to 
their toxicity. Protein misfolding and aggregates can disrupt chromatin organization, 




export (reviewed inGallagher et al, 2014). Proteins often misfold due to mutations, errors 
in processing, chaperone failure, post-translational mistakes, and structural changes due 
to the environment. Self-aggregation is the most common consequence of misfolded 
protein. Protein aggregates are often rich in β-sheet structural motifs and can 
accommodate an unlimited number of polypeptide chains (Nelson et al, 2005). In 
experimental models, misfolded proteins have been shown to propagate to neighboring 
cells and are a prevalent hallmark in neurodegenerative diseases and other brain 
debilitating disorders including, Alzheimer’s disease (AD), Parkinson’s disease (PD), 
amyotrophic lateral sclerosis, and Huntington’s disease (HD) (Davis et al, 1994; Conway 
et al, 2000; Chiti et al, 2002). Since neurons are particularly vulnerable to misfolded 
proteins, studies have been looking into the protective roles of HSPs as a way for 
prevention and treatment.  
 As previously discussed, HSPs play an essential role in proper protein folding, not 
only of newly synthesized proteins but also those subject to stress-induced denaturation. 
The Hsp70 family of chaperone proteins is one of the most extensively studied and vastly 
versatile, involved in several fundamental biological processes (reviewed in Mayer & 
Bukau, 2005).  In the CNS, Hsp70 is expressed in the brain under several kinds of 
stressful conditions, such as hyperthermia, ischemia, trauma, and excitotoxicity (Ohtsuka 
& Suzuki, 2000; Rajdev et al, 2000; Brown, 2007; Obrenovitch, 2008). Furthermore, 
several studies have shown that elevation of HSP70 levels had a protective effect on 
neurodegeneration models. This phenomenon is observed in polyQ diseases, including 




expansions of the polyQ stretch in the disease-causing proteins, triggering protein 
misfolding, and deposition in inclusion bodies. In Drosophila models for SCA, induction 
of molecular chaperone proteins by HSF1 activation suppressed compound eye 
degeneration, and inclusion body formation. The same study also showed that 
neurodegeneration was suppressed when Hsp70, Hsp40, and Hsp90 expression were 
induced by HSF1 in the Drosophila model for HD (Fujikake et al, 2008). In a mouse 
model for HD, the deletion of Hsp70 proteins exacerbated the neuropathology of the 
disease, thus increasing the size of inclusion bodies (Wacker et al, 2009).  
 The neuroprotective roles of Hsp70 chaperone proteins have also been observed 
in PD, where dopamine neurons from the substantia nigra develop toxic cytoplasmic 
aggregates that lead to neurodegeneration (Conway et al., 2000; Chiti et al., 2002). In 
Drosophila, directed expression of Hsp70 prevented loss associated with α-synuclein, 
and interference with chaperone activity accelerated its toxicity (Auluck et al, 2002). 
Similarly, in an α-synuclein transgenic mouse model and in an in vitro model of α-
synuclein aggregation, the introduction of Hsp70 led to a significant reduction of α-
synuclein aggregates and protected cells from α-synuclein-induced cellular toxicity 
(Klucken et al, 2004; Dedmon et al, 2005; Huang et al, 2006). The relationship between 
HSPs and various types of amyloid-β has also been investigated in AD, a disease driven 
by the formation and aggregation of amyloid-β peptides in the brain parenchyma and 
around the cerebral vessel walls. An in vitro study showed that recombinant Hsp70, 
Hsp40, and Hsp90 may block amyloid-β self-assembly (Evans et al, 2006). Another 




expression of interleukin 6 and increased the clearance of amyloid-β peptides (Kakimura 
et al, 2002). Thus, Hsp70s are a critical component of the cellular defense against the 
toxic effects of misfolded proteins, and overexpression of these proteins may lead to 
treatments of neurodegenerative diseases.  
FOXR1 may play a role in protection against proteotoxic stress by inducing the 
expression of Hsp70 family proteins (HSPA1A and HSPA6) and DHRS2, and the lack of 
their expression in the M280L mutant may lead to neurological pathogenesis in the 
individual. It is well established that several FOX transcription factors have important 
biological functions in brain development where mutations in FOX genes have profound 
effects on the proper development and function of the brain. Human genetic analyses 
show that mutations in FOX genes have profound effects on the development and 
function of the brain. For instance, disruption in FOXG1 in humans leads to structural 
brain abnormalities including microcephaly and agenesis of the corpus callosum 
(Shoichet et al., 2005; Kortum et al, 2011; Hettige & Ernst, 2019).  In addition, human 
mutations in both FOXP1 and FOXP2 lead to severe speech and cognitive impairments 
(Lai et al., 2001; MacDermot et al, 2005; Takahashi et al., 2009; Horn et al., 2010; Nudel 
& Newbury, 2013; Han et al, 2019) where both genes have also been linked to autism 
spectrum disorders (Takahashi et al., 2009; Mukamel et al., 2011; Bowers & Konopka, 
2012b, a). In summary, our results suggest that the FOXR1 plays a protective role during 
the cellular stress response, and because M280L mutant misfolds and is less stable at the 





General Discussion   
6.1 Major findings  
Through whole-exome sequencing, the UDN at NIH identified a mutation in a 
single allele of the FOXR1 gene linked to an individual with severe neurological 
symptoms including postnatal microcephaly, progressive brain atrophy and global 
developmental delays. FOXR1 is a member of the evolutionarily conserved Fox family of 
TFs named after the ectopic head structures observed in mutants of the Drosophila gene 
fkh. Since the discovery of fkh 30 years ago, hundreds of Fox genes have been identified 
ranging from yeasts to humans, making it one of the largest families of higher eukaryotic 
TFs. Human genetic analyses revealed several FOX genes have important biological 
functions associated with brain development such as FOXG1 (potential determinant of 
forebrain size) and FOXP2 (vocal learning). Further, mutations in FOXG1, FOXC2, 
FOXL2, FOXP1 and FOXP2 have profound effects on human brain development 
including microcephaly, intellectual impairments, and language disorders. Despite the 
vast number and distinct roles of FOX proteins, all members harbor a core fkh DNA-
binding domain that regulates the transcription of large array of genes directing major 
biological processes.  
In chapter 3, we demonstrated how a single de novo missense mutation in FOXR1 
leads to robust changes in FOXR1 protein expression. The M280L mutation in FOXR1 
leads to an 83% decrease in FOXR1 protein expression when we transiently expressed 




for GFP from similar transient transfection experiments showed expression of FOXR1 
WT mainly in a diffuse pattern in the nucleus co-localized with DAPI nuclear marker. In 
contrast, the M280L mutant formed discrete nuclear puncta ranging from >15 puncta 
with an average size of <2 μm2 to nuclei containing <5 puncta with aggregates of >4 μm2 
suggesting that the larger puncta form by coalescing from small nuclear foci. We found 
the decrease in FOXR1 protein expression in cells transfected with the M280L mutant 
was due to protein instability, suggesting that the M280L destabilizes FOXR1 protein, 
making it susceptible to proteolysis and degradation through the proteasome pathway. C-
terminal truncation of FOXR1 replicated the M280L mutant phenotype which further 
supports the conclusion that the C-terminal sequences are crucial for FOXR1 stability. In 
summary, the results from chapter 3 demonstrate that the human FOXR1 M280L mutant 
leads to a decrease in FOXR1 protein stability.  
 Fox TF’s regulate the transcription of major cellular processes, including cell 
cycle control, stem cell function and maintenance, detoxification of ROS, DNA repair, 
and apoptosis. FOXR1 harbors a core fkh DNA-binding domain, suggesting it has the 
ability to control gene transcription. However, little is known regarding what target genes 
are regulated by FOXR1. In chapter 4, we identified potential target genes regulated by 
FOXR1 based on an unbiased transcriptomic screen by RNA-seq in HEK 293T cells. 
Differential gene expression analysis suggested that FOXR1 acts as both a transcriptional 
activator and repressor. The most highly upregulated genes in response to FOXR1 WT 
expression, but not significantly upregulated in response to FOXR1 M280L included two 




DHRS2. Each of these proteins plays a role in protecting against oxidative stress-
mediated cellular response. In addition, the top FOXR1-regulated genes HSPA6, 
HSPA1A and DHRS2 contain FOXR1 response elements within their upstream regulatory 
regions and are direct targets of FOXR1; the M280L mutation abolishes the ability of 
FOXR1 to activate the expression of these target genes. In addition, we demonstrated that 
an HSF1 binding site in the FOXR1 promoter enhances its transcription, suggesting that 
FOXR1 is a direct target of HSF1. HSF is a master TF responding to stress, perhaps with 
cross-talk to FOXR1 to fine-tune transcription of target genes in response to specific 
stress stimuli. In summary, the results of chapter 4 suggest that FOXR1 is a participant in 
cytoprotective pathways that regulate a cell’s stress response. 
In chapter 5, we demonstrated how different stress paradigms affect FOXR1 
expression in transiently-transfected cells. FOXR1 WT demonstrated an increase in 
protein expression in serum- and CO2-deprivation. However, FOXR1 M280L expression 
was only increased under CO2-deprivation, as observed by an increase in puncta 
formation in the nucleus. This indicated that the M280L mutant maybe sensitive to 
different types of stressors. To further characterize the relationship between FOXR1 and 
oxidative stress, we treated cells with PMA, a known inducer of ROS, and found an 
increase in protein expression in FOXR1 WT and M280L mutant after 24 hours. We also 
showed an increase in both HSPA6 and DHRS2 protein expression levels only in cells 
transfected with FOXR1 WT, suggesting that FOXR1 may play a role in alleviating 
oxidative stress in cells. We also determined that the puncta formation in the M280L 




genes in the M280L mutant is probably due to misfolding of the FOXR1 protein itself. 
This dissertation provides the first steps into gaining insight into the cellular function of 
FOXR1 and how the human M280L mutation impairs its function.  
6.2 The role of FOXR1 in brain development  
FOXR1 is a member of the Fox gene family and is genetically linked to an 
individual with severe neurodevelopmental abnormalities. However, it is unclear how 
alterations in FOXR1 predispose individuals to neurodevelopment disorders. Based on 
GTEx tissue gene expression profiles, FOXR1 is expressed in the human brain and 
reproductive organs (Consortium, 2013). Expression data for FOXR1 can also be found 
in several online web resources that provide some clues to its importance during brain 
development. The Human Brain Transcriptome shows that FOXR1 is expressed in all 
brain regions during postnatal development and its expression level in the brain is 
maintained throughout life (Figure 1.3A). Using in situ hybridization, mouse foxr1 
expression was seen in all brain regions and enhanced within the nucleus, consistent with 
the human tissue expression profile (based on Allen Mouse Brain Atlas). We also 
surveyed mouse foxr1 expression at various tissues at embryonic day 17 (E17) and found 
a 300-fold increase in the brain compared to the heart (Figure 1.3B). However, currently 
lacking is a detailed examination of foxr1 protein expression in the brain at the cellular 
and anatomical level during prenatal and postnatal brain development. Based on these 
findings we hypothesize that the disruption in FOXR1’s ability to regulate downstream 
target genes by the M280L mutation leads to vulnerability to neurodevelopment disorders 




We have acquired mice that lack the foxr1 gene. Preliminary data shows that these 
KO (knockout) mice exhibit a severe survival deficit. Genotypes of offspring at postnatal 
day 21 (P21) from heterozygous foxr1+/- crossings did not identify any foxr1-/- KO mice 
indicating early lethality for the lack of foxr1 (Figure 6.1A). Even though the number of 
litters analyzed was small, there was also a decrease in the anticipated number of 
heterozygous foxr1+/- mice suggesting that loss of a single allele of foxr1 also affects 
survival. We next examined whether foxr1 KO was lethal during embryonic development 
or within the first postnatal weeks. To test this, we analyzed the genotypes of offspring 
immediately after birth (newborns) and found 50% of foxr1-/- KO mice survive through 
embryonic development (Figure 6.1A). In addition, surviving foxr1-/- KO newborn mice 
had significantly reduced body weight with no milk in their stomachs compared to their 
littermates (Figure 6.1B). Examination of newborn foxr1-/- KO brains by immunostaining 
with the cytoskeletal marker MAP2 revealed a decrease in cortical thickness and enlarged 
ventricles across brain sections compared to littermate WT mice, suggesting that the 
architecture of the brain is dependent on foxr1 (Figure 6.1C).  
 To extend our current findings we can determine the location and timing of 
FOXR1 in the developing brain by utilizing the KO mice to determine the mRNA and 
protein expression profile of foxr1 in brain development. Since we observed a thinner 
cortex in surviving newborn foxr1-/- KO mice, it would be important to determine whether 
foxr1 contributes to the patterning of the cortex and other brain regions.  Additionally, it 
would also be important to conclude if foxr1 regulates neural progenitor proliferation 




microcephaly and progressive brain atrophy. It is likely that there are changes in 
progenitor proliferation and/or cell death in both foxr1+/- and foxr1-/- KO mouse brains.  
Given that foxr1-/- KO mice phenocopy some of the pathological changes the 
proband carrying the FOXR1 M280L mutation, it would be important to investigate 
whether similar underlying cellular features are present in the individual. We have skin 
fibroblasts obtained from unaffected carriers and the affected individual with the M280L 
variant. For further studies, these cells can be reprogrammed and induced into pluripotent 
stem cells (iPSCs) capable of indefinite self-renewal and differentiation into multiple cell 
types. These cells can be differentiated into cortical neural cells and we can assess for 
expression of maturation-associated markers as compared to primary human control cells. 
Based on molecular evidence regarding the M280L mutation, we anticipate that FOXR1 
expression will be decreased in iPSC-derived cortical cells and fibroblasts of the 
individual line compared to the carrier.  
6.3 FOXR1 transcriptional regulatory program during brain development  
 In chapters 4 and 5, we focused our analyses on the top upregulated FOXR1-
controlled genes, HSPA1A, HSPA6, and DHRS2. However, the RNA-seq analysis also 
showed upregulated genes involved in ribosome biogenesis (RRS1, ribosome biogenesis 
regulator 1) and nervous system development (MTURN, PDZD8, PTPRZ1, NOTCH2). 
Since HEK 293T cells and neurons originate from neural crest cells, this might explain 
the expression of several neuron-specific genes (Shaw et al, 2002). Ribosome biogenesis 
is a key driver in neurodevelopment and dysregulated ribosomal biogenesis has shown to 




neurodegeneration (Hetman & Slomnicki, 2019). Also, ribosome assembly is an energy-
demanding process and alteration of any step in ribosomal biogenesis is highly prone to 
proteotoxic stress that triggers rapid activation of a specific stress pathway that 
coordinately upregulates heat shock target genes. It is possible that FOXR1 plays a role 
in protection against proteotoxic stress during ribosome assembly which is essential in 
brain development. It is possible that FOXR1 regulates crucial genes to balance growth 
with protein homeostasis necessary for brain development. Understanding how FOXR1 
regulates the transcription of genes and how this influences brain development are 
important questions to address. 
6.4 Mechanism underlying the regulation of foxr1 and its function in stress in the 
brain 
During embryonic brain development, neuronal and glial progenitors must survive 
a relatively hypoxic microenvironment and take on energetically expensive tasks such as 
neurite outgrowth and cell migration (Miller & Fort, 2018). These events must work in 
concert so that neurons form the appropriate synaptic connections and receive support 
from glial cells. Environmental exposure during gestation that causes stress has been 
shown to alter prenatal brain development and increase the risk for neurodevelopmental 
disorders (Estes & McAllister, 2016). We have shown that FOXR1 expression is 
increased following stress-induced conditions and regulates genes related to 
cytoprotective pathways alleviating oxidative stress in vitro. However, it remains elusive 
the role FOXR1 plays in the regulation of transcriptional signaling cascades that are 




Epidemiological evidence implicates maternal infection as a risk factor for autism 
and schizophrenia. Animal models corroborate this link and demonstrate that maternal 
immune activation (MIA) and stress alone is sufficient to impart lifelong neuropathology 
and altered behaviors in offspring (Estes & McAllister, 2016). Because of the role of 
FOXR1 in development and regulation of stress-response we can determine whether MIA 
stress impacts fetal brain development differently in heterozygous foxr1+/- as compared to 
littermate control mice. This can be tested in pregnant female from heterozygous foxr1+/- 
crossings with a single injection of LPS or saline control. We can characterize the 
offspring of LPS-treated dams for gross anatomical changes and aberrations in cortical 
lamination using the markers. Taken together, these studies will determine the 
relationship between environment, stress and foxr1 in neurodevelopment.   
6.5 The role of stress in post-translational modification of foxr1 function 
 Fox proteins are known to be regulated by a variety of PTMs including 
acetylation, phosphorylation, and ubiquitination (Lam et al, 2013). In an unbiased mass 
spectrometry study, two FOXR1 phosphopeptides (S237, T244) were identified in LPS-
stimulated macrophages from mice and not in the non LPS-stimulated mice  (Wu et al, 
2012). Thus, regulation of FOXR1 PTMs by LPS supports a role for FOXR1 regulation 
in response to stressful stimuli. Based on NetPhos 3.1 server which predicts 
phosphorylation sites in eukaryotic proteins using ensembles of neural networks, T244 is 
predicted to be phosphorylated by Protein Kinase C (PKC). Given that PMA is a known 




possible that phosphorylation of T244 by PKC regulates FOXR1 protein expression 
levels in response to stress. 
 To determine stress-induced phosphorylation sites for FOXR1 in an unbiased 
manner, we can perform tandem mass tagging spectrometry to identify and quantitate 
specific phosphorylation sites on FOXR1 in HEK 293T cells following PMA treatment. 
We can mutate sites to phospho-mimetic (site-directed mutagenesis to aspartate) and 
phospho-resistant (mutate to alanine) mutants and determine the role of these residues in 
FOXR1 function. The functional readouts of PTM-modified FOXR1 mutants will include 
gene expression profiles, degradation, DNA-binding activity and upstream regulatory 
region activity (e.g., HSPA6 and DHRS2), protein-protein interactions and subcellular 
localization. Since FOXR1 was shown to be associated with the NuA4 histone 
acetyltransferase (HAT) complex based on STRING analysis (Figure 6.2; (Li et al, 
2016)), and histone acetylation has been shown to be elevated by heat stress (Zhou et al., 
2018), we can also test whether acetylation of FOXR1 affects FOXR1 DNA binding 
activity. We can treat FOXR1 transfected HEK 293T cells with stressors such as PMA 
and determine whether FOXR1 acetylation is altered by immunoprecipitating WT 
FOXR1 and detecting with a pan-acetylation antibody. There are five lysines (K75, 91, 
112, 118 and 151) in the second disordered regions of FOXR1 that can serve as potential 
acetylation residues (Figure 6.3). In addition to acetylation, lysines are also targets of 
ubiquitination which can be downregulated following stressors such as sustained 
oxidative stress (Shang & Taylor, 2011). Since we found increased FOXR1 protein levels 




condition, FOXR1 is not being degraded. Four lysines (K20, 38, 67 and 233) are 

























Figure 6.1 Foxr1 is an essential gene for the survival of mice 
A, Genotype analysis based on the number of offspring at postnatal day 21 (P21) and 
newborns from heterozygous foxr1+/- crossings. B, Body weight in grams (g) of newborn 
pups. C, Coronal brain sections of MAP2 immunostaining and quantitative analysis for 
foxr1+/+ WT and foxr1-/- KO mice showing a decrease in cortical thickness and enlarged 
























Figure 6.2 Network of interactions between FOXR1 binding proteins using STRING  
Analysis of the FOXR1 interactome using STRING revealed an interconnected sub-
network containing MYC and the proteins associated with the NuA4 histone 






Figure 6.3 Post-translational modification sites for FOXR1 
Five lysines (marked in black, K75, 91, 112, 118 and 151) were identified as potential 
residues for acetylation (http://pail.biocuckoo.org/wsresult.php). Two phospho-sites 
(S237, T244) were identified based on an unbiased mass spectrometry screen in response 
to LPS (Wu et al., 2012). Four lysines (K20, 38, 67 and 233) conserved between humans 







FOXR1 interacts with MYC in the presence of SAHA, an HDAC inhibitor 
1.1 Introduction   
 FOXR1 shares 57.7% sequence similarity with FOXR2 (Katoh & Katoh, 2004b). 
A FOXR2 study evaluated raw interaction data and identified MYC and MAX, as well as 
many MYC associated proteins, on High-confidence Candidate Interacting protein 
(HCIP) lists of FOXR1 and FOXR2 chromatin fractions (Li et al., 2016). Because 
FOXR1 was not detected in any of the cell lines tested, the study only highlighted 
FOXR2’s functional role in promoting cell proliferation by regulating MYC 
transcriptional activities. Further analysis of the FOXR1 interactome using STRING 
analysis revealed an interconnected subnetwork connecting FOXR1 to MYC and the 
NuA4 histone acetyltransferase complex (Franceschini et al, 2013). MYC is well known 
for its role in oncogenic processes since it is downstream of important pathways such as 
cell growth and proliferation (Dang, 2012). MYC function is regulated by NuA4/Tip60 
and the association increases cellular proliferation (Zhao et al, 2018). Even though this 
function of FOXR2 has been elucidated, little is known about FOXR1’s role in relation to 
MYC.  
Results 
To determine whether FOXR1 interacts with MYC and MAX, we generated 
pCMV-HA MYC and MAX constructs. HEK 293T cells were transfected with either 
GFP, GFP-tagged FOXR1 WT or M280L with either p3XFlag tagged MYC or MAX. 




immunoprecipitate with FOXR1 (data not shown).  Since the interactome studies also 
showed FOXR1 interacting with members of the NuA4/TIP60 HAT complex, we decided 
to increase acetylation by inhibiting histone deacetylases in order to observe the effect on 
HEK 293T cells expressing FOXR1 WT and M280L. We transiently transfected HEK 
293T cells with GFP, GFP-tagged FOXR1 WT or M280L mutant and treated with 
Suberoylanilide Hydroxamic Acid (SAHA), a histone deacetylase (HDAC) inhibitor. 
Following a 24 h treatment with SAHA, we performed a fractionation analysis and 
observed an increase in FOXR1 WT and mutant expression in the cytoplasmic and 
nuclear fractions (Appendix Figure 1.1). This upregulation of FOXR1 expression was 
also verified with two other HDAC inhibitors, Trichostatin A (TSA) and Panobisostat 
(data not shown). The increased expression in the FOXR1 M280L mutant correlated to an 
increase in puncta formation.  
Since we observed FOXR1 protein expression was increased in cells treated with 
SAHA, we also observed a significant increase in both HSPA6 and DHRS2 protein 
expression levels in cells transfected with FOXR1 WT in both cytoplasm and nuclear 
fractions (Appendix figure 1.2). Although we observed changes in HSPA6 and DHRS2 
protein expression levels in cells transfected with M280L, the increase did not equate to 
that of the WT. In addition, while we observe a significant increase in HSPA1A mRNA 
levels in cells transfected with FOXR1 WT (Figure 4.6), we did not detect any changes in 
HSPA1A protein levels in cells transfected with FOXR1 WT or M280L. 
 To determine if FOXR1 WT and M280L interacted with MYC and MAX when treated 




M280L with both p3XFlag-MYC and HA-MAX. We treated cells with SAHA for 24 h 
and performed immunoprecipitation assays. We determined that MYC did co-
immunoprecipitate with both WT and mutant FOXR1 in the presence of SAHA 





Appendix Figure 1.1 FOXR1 expression in increased in the presence of SAHA  
A, Representative immunoblots of GFP-FOXR1 from HEK 293T cells transfected with  
with GFP, and GFP-tagged FOXR1 WT and M280L mutant. Cells were either treated 
with SAHA or left untreated, lysed, and the nuclear and cytoplasmic fractions were 
separated. B, Quantification of Western blots. C, Fluorescence images of HEK 293T cells 
expressing GFP-tagged FOXR1 WT and M280L mutant with and without SAHA 
treatment.  D, Quantification of total GFP FOXR1 signal of fluorescence images. E, 
Percentage of cells with puncta formation in cells expressing FOXR1 M280L mutant 






Appendix Figure 1.2 SAHA increases expression of FOXR1’s target genes  
Representative immunoblots and quantification analysis of subcellular fractionation 
studies of HEK 293T cells transfected with GFP, and GFP-tagged FOXR1 WT, and 
M280L. Cells were then treated with SAHA. Increase in FOXR1 levels correlates with 






Appendix Figure 1.3 FOXR1 interacts with MYC and MAX when treated with 
SAHA 
Representative immunoblots of co-immunoprecipitation of FOXR1 with MYC and 
MAX. HEK 293T cells were triple transfected with GFP, FOXR1 WT, or M280L mutant 
with Flag-MYC and HA-MAX. Cell were treated with SAHA and collected 48h post-
transfection, immunoprecipitated (IP) with GFP antibody, and immunoblotted for Flag, 
HA, GFP, and GAPDH (control) antibodies. The results show interaction of FOXR1 WT 




2.1 FOXR1 expression pattern in primary neuron cultures  
Results  
To determine the expression pattern of FOXR1 in primary neuron cultures, we 
prepared and infected primary neurons with pFUW-FOXR1 WT and pFUW-FOXR1 
M280L on DIV 3. On DIV 15 neurons were fixed on coverslips in 4% paraformaldhyde 
at room temperature for 10 min, and then permeabilized and blocked for 20 minutes. 
Primary antibody incubation with GFP and MAP2 was performed with 5% goat serum in 
PBS overnight at 4°C. After washing with PBS, neurons were incubated with secondary 
antibodies for one hour at room temperature. Coverslips were then washed in PBS and 
mounted in ProLong Gold with DAPI. Images were taken a Carl Zeiss LSM 700 laser 
scanning confocal microscope. Similar to the HEK 293T expression pattern, 
immunostaining for GFP showed expression of FOXR1 in the nucleus co-localized with 
the DAPI nuclear marker (Appendix figure 2.1). We did not observe puncta formation 







Appendix Figure 2.1 FOXR1 overexpression in primary mouse neurons  
Representative images of primary hippocampal neurons infected at DIV 3 with GFP-WT 
or GFP-M280L, fixed at DIV 15 and immunostained for MAP2 (red). Expression of 


























Appendix Figure 3.1 Upstream regulatory sequences for HSPA1A, HSPA6, DHRS2, 
and FOXR1 
Upstream regulatory regions showing FOXR1 response elements lie upstream of the 
HSEs in both the HSPA6 and HSPA1A promoters. In addition, we identified a consensus 
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